"YearStart","YearEnd","LocationAbbr","LocationDesc","DataSource","Topic","Question","DataValueType","DataValue","DataValueFootnoteSymbol","DatavalueFootnote","StratificationCategory1","Stratification1","GeoLocation","LocationID","TopicID","QuestionID","DataValueTypeID","StratificationCategoryID1","StratificationID1","Longitude","Latitude"
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",121,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3056,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2022,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",260,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1576,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",271,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",350,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",322,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",59,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",235,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12064,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",141,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2570,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1440,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",453,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1436,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4316,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7257,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2148,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5975,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",128,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1613,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2053,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6282,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",110,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",185,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",88,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3240,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9385,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8150,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2644,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",221,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6261,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1048,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1550,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3402,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1947,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9283,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",348,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",1670,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",46763,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",175,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2464,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",39,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3288,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",47,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1269,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2836,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",3565,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1031,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",272,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",295,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",615,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",475,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6141,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6974,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5588,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",350,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4754,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1008,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",327,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3626,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",573,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",79,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11692,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2067,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3044,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",31,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2693,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3442,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2259,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",150,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6612,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1135,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1857,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",282,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",618,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",29,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",46,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",245,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",154,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",761,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",65,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4025,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2719,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1434,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6253,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",494,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",14155,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",698,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",668,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7466,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4202,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1231,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5038,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7160,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",83,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2123,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",362,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2747,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2126,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7850,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1644,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3542,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",652,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1017,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6863,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11168,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",209,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1547,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",576,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3090,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",11328,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2505,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10081,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",126,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2454,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",75,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14029,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",189,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3141,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",122,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",613,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",42,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",2513,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",138,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",29415,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6860,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",89,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",905,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2735,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",840,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",41459,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3803,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5197,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",116,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4221,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1491,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",570,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2421,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",130,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7428,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5343,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",361,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",110,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",47,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5925,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",267,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",54,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",756,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7287,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6987,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17676,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",131,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1221,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2153,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1454,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",56,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",161,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",282,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1914,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4335,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1085,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2652,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",34,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",481,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2204,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",752,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",44,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8036,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2338,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",455,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3506,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4935,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2805,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",42,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",105,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10472,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",148,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",772,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",416,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1766,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",276,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",96,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8171,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4705,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",108,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",62,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1454,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",553,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4780,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1827,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",636,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",291,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4910,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",49,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5457,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1325,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",87,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1364,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3626,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",68,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",180,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8978,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2197,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",491,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",100,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2010,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1167,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",184,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3142,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",291,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",524,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13165,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1098,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",675,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3109,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2140,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7097,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1331,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1085,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",281,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1112,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1142,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",29,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",59,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2153,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5562,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",375,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3950,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",642,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2480,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",815,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",104,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10196,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",952,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",415,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",184,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",269,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",76,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6186,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",216,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1724,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",236,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2546,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",455,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1196,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",70,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",99,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",66,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3088,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",323,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",310,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2055,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",178,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4307,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",108,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4150,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",161,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3840,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1827,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",762,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3663,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",226,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",280,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",120,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1712,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",441,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8474,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2005,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3281,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3469,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",188,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",46,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",850,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",104,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",402,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",122,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",40,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",178,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",201,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",171,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1740,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4508,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",53,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13473,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",561,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2913,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",102,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",48,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1130,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5111,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9202,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",143,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",862,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",381,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",26356,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4419,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",679,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3181,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3188,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3176,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",15883,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1953,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15388,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3541,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1412,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",177,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",559,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5296,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",12653,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",2645,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6281,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",18313,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",87282,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",31069,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",499,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",174,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",15883,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",23493,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",113,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",391,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",23232,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6279,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",19778,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10515,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1725,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1861,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",381,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",77,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",7144,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",416,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3254,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5833,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",77,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2542,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6332,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10004,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9682,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",42,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",872,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",13093,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",75,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3541,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",10355,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18594,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7731,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",101,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",303,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1551,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1260,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",576,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15270,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2054,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6814,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",261,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",889,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7567,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",1162,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",198,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",12877,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2542,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7173,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5563,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",179,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4087,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",268,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",366,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5475,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",79,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",12756,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28256,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",449,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3096,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",235,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",13600,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",14308,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",18313,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",45387,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1218,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",98,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",97,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",9928,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1278,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",5390,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2234,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1489,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",223,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5147,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3097,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",227,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",62547,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9081,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6851,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4749,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1347,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",54217,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4690,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",576,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1787,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7424,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6714,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",30,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",384,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1792,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22077,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",9570,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",227,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",1907,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",12455,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3188,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2161,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",39934,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4419,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2221,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",247,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13141,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",58,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",838,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",576,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",559,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",8791,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1389,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1123,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2713,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2965,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",273,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5396,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",424,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3309,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2324,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",16457,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",730,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",25216,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",713,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13296,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2033,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",53,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3235,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7059,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6485,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3254,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1792,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",98,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",88,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5334,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2702,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",156,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1921,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",253,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10938,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",2096,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",116,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",9313,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",64,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8791,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",641,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2221,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",74,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",268,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1123,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4063,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3708,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",14308,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",158,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",261,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",598,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",49663,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4012,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",34291,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6033,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",3483,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",158,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",481,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16812,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2401,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1389,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",41895,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",200,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",32621,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",37465,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2877,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",36,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1174,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",178,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4785,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1946,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",572,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",314,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5089,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",47,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1697,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8430,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3078,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1388,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5453,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",718,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",210,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",92,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",71,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",491,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1252,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2285,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",243,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",282,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2684,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",114,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2767,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",85,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",430,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5840,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",382,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",128,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",243,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",145,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",177,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",51,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",656,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4530,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3273,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1637,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1314,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",643,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",791,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",318,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",972,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",972,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",44,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",172,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1956,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1180,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",422,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",74,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2351,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",30,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",719,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1896,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",518,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3291,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",349,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",212,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3132,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",210,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",75,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",832,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",50,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2951,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",87,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3193,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",838,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2351,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1369,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",160,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2096,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4297,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1363,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1996,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",124,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",192,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1221,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1637,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",286,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1430,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",61,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",102,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3722,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1124,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",457,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1625,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1032,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",118,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",743,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",173,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",187,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3794,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3095,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1073,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3132,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",861,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",272,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",37,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2440,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4894,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",39,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",560,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",421,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",124,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",292,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6258,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",71,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",238,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",51,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1124,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",64,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3864,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",87,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",536,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",226,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",402,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2353,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",42,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7205,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",103,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",448,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1295,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",820,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2294,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1254,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",525,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4566,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7370,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",652,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",131,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",816,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6162,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",272,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1178,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1946,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2762,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1681,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",143,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",743,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",187,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",306,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1239,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5279,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1325,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1745,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",246,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9315,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3564,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",550,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",337,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2566,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",59,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",35,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",192,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2097,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",144,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",89,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8061,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",50,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5063,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",266,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10173,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",714,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",132,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3641,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7333,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3701,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1869,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4079,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",448,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5738,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2848,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",936,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",2103,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",183,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1718,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",283,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",513,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6492,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",812,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",252,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",339,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",36916,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",205,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",490,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",287,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",515,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",109,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6302,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2194,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",73,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",9908,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11507,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",204,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5748,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",154,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1124,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",752,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",446,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",235,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",26276,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",47829,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",29510,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",10214,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",273,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",605,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",452,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2754,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",349,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",76,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",35100,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",87,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",731,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2030,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",1242,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7605,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",25148,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1075,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",13209,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",12050,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",473,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1051,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",23636,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",519,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2451,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",450,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",9280,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",165,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2451,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",777,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",300,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1677,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",65203,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",124,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",822,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2187,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",266,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7471,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4629,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",454,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1223,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2790,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2001,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",452,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1129,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",435,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",56,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",522,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",30813,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5138,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",519,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",7667,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",20751,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",12129,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",283,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","GENDER","GENM",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1696,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",9908,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",228,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22630,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1299,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1122,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3967,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",89,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",420,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",6974,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",114,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",34390,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",55,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",574,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1324,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",17432,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2754,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",19995,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",232,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",377,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",61,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",2621,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",467,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",205,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",11420,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1475,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",13255,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9112,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",41,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",47027,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",14286,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",908,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",463,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",33,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",667,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",180,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",965,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",11420,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",205,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",82,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",300,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",16882,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",518,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1607,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",12078,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","AIAN",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",204,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1466,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","API",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",517,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",667,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",463,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",656,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2105,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8849,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",155,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",110,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",46,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2018,2018,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22284,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",3345,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",723,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3066,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",70,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",274,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",122,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",675,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",585,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",343,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4861,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",650,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3630,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",240,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",115,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",49,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",479,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",229,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",272,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",191,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",113,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4148,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2768,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4028,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1672,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4836,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13164,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4553,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11247,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2915,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",410,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2768,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3980,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",736,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",131,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",95,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3213,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",879,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",39,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11453,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",154,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",964,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8125,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",331,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",144,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",124,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1963,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1746,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6092,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",191,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3213,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1939,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1966,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2522,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1393,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7902,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",1171,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",712,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",712,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2557,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",52,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17200,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2982,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",353,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",144,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",160,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10430,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7430,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",435,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3177,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7746,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",124,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",410,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",786,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1191,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",195,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",137,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",127,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",553,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",905,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2587,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",31,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",553,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",329,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4097,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",81,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",905,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",103,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",102,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5311,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",461,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1098,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13322,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",18986,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4148,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",479,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4123,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2304,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",433,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",175,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",874,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",643,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8556,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",69,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1472,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1313,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",464,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",251,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",834,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1176,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6816,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5741,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",294,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1432,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",451,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3566,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2311,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3980,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",416,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",25386,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",30,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",228,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",910,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6716,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",212,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",347,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1958,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18993,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7193,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",618,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1306,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",120,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",201,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3359,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",12113,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",502,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1602,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1464,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",286,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13440,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3033,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1105,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3803,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7185,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",35,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1829,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3786,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2979,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2387,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1451,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1497,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4720,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",776,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",141,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",181,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",106,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4267,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",674,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6970,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1908,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1517,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1023,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",19867,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",500,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2063,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",107,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3786,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5780,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",25906,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",537,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1055,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",931,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",128,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1666,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1762,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",214,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",8341,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2633,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12645,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3008,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10268,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2473,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4837,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9131,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1577,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",30,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",1421,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2179,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",553,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1713,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",170,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",919,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13642,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",928,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",570,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",857,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3327,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",928,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",103,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",845,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",73,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8267,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5375,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",54,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3163,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",146,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4480,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",674,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1908,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1774,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",67,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",556,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",12682,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",251,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",471,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3122,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5105,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9427,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",166,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1490,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2262,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",20612,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",875,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3858,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5970,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5970,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1490,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16841,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",46,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",937,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1794,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",57,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1464,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",589,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1021,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1568,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",419,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6083,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1363,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",683,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",153,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4605,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1045,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4093,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",41,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",30,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",432,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4481,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",205,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",1028,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",329,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",249,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1503,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",595,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1119,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1741,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8864,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",57,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",751,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",65,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1282,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",25,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4374,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3894,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4178,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4481,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",458,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1923,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",951,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",718,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2405,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5855,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3895,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",96,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3163,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25755,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1759,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17271,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",204,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",553,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",34112,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5425,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",106,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",198,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5470,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",286,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4245,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7967,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3382,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10043,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",969,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2437,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1831,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2170,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",72,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",417,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1451,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1386,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",208,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",863,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",28,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4822,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4893,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",25,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",251,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5878,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",929,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1434,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8727,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",171,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",307,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19118,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5823,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2189,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7808,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",176,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1553,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2426,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8001,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9308,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1229,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3383,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",416,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",426,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",717,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",425,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3231,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",545,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",190,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1542,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",60,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1861,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",118,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",122,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3308,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3667,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",258,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",686,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3213,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4190,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2718,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",39,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1317,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1562,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7975,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3953,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2000,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6724,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7279,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2987,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",149,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",864,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",102,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",113,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5878,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2814,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",9325,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9810,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3175,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",459,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10989,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",74,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",55,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",246,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",109,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4701,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",975,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4693,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",751,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",686,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",113,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",73,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12606,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",44,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3392,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",266,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",87,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1826,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",85,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",48,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6726,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1038,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13084,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5269,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1325,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",342,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4844,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5058,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",260,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1660,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",981,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",55,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",299,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6567,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",100,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1051,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",173,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4223,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4624,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12908,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1778,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",686,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",392,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1051,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3091,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13704,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3051,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3635,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1383,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7088,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2485,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",855,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",360,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",176,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",258,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4660,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2983,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4022,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7187,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1784,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3358,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",115,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2082,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",771,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1587,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",56,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3105,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6426,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2267,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1296,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7427,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2114,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",60,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17146,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3091,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",64,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7850,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1151,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",639,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1950,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1669,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4508,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14532,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3635,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3760,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",137,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",214,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",40,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",82,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",100,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3151,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",284,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",576,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",198,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7278,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",512,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",29,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1173,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2114,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",122,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5734,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4025,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1580,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2471,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",289,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",668,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1062,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2655,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5803,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3611,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2086,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15781,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3001,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",189,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2161,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",299,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2485,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2496,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",118,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2466,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2204,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",253,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",205,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10698,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2036,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1431,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2619,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7892,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1423,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9348,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1157,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",393,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",249,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1857,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",368,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",145,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",49,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2356,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",304,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4409,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6160,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",86,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3090,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2277,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",967,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4712,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3580,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",76,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",30,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1840,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9585,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7596,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4016,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",327,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3324,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5975,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5136,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3307,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",45,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2086,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",64,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",73,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2466,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3992,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",67,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",324,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3001,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1601,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",96,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",146,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1543,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1193,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",314,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",958,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1000,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14030,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3492,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2149,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",554,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",441,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",30,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",864,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2356,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1246,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6114,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",162,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",157,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6982,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9844,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5180,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4757,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2210,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2227,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4896,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",791,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",741,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",184,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",82,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4084,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5442,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5292,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",314,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",686,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",310,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",12036,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",777,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7778,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",624,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",67,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3561,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",147,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5940,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4367,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",554,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",487,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",99,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4124,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5640,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3932,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9792,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1543,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6001,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1477,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2551,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1217,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5754,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1798,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7889,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2157,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14526,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1074,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10238,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6496,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",209,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1466,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",83,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1930,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",230,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3545,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10697,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2267,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3611,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",127,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",168,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7544,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",515,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",762,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",101,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",253,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1498,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3446,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6057,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",837,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",327,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10823,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4498,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3083,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11340,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3324,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2227,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",530,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1930,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1574,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",112,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4151,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1818,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",139,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5633,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5111,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1048,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2339,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",110,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1841,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",410,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",25,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",167,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4457,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",782,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",274,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1708,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2959,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1490,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",448,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2615,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",132,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3981,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",206,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",696,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",50,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7797,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2720,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",696,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",966,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1884,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1595,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",489,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",198,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",139,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2916,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",95,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5638,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1201,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",810,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11215,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",528,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1229,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",1310,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3396,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1698,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6533,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",912,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",475,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",528,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2318,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5582,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2487,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",103,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",241,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7758,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3642,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",1068,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1722,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1648,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",71,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",302,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4733,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5508,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2720,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",913,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3941,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",295,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10327,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2965,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3366,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11683,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",331,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2057,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3736,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",912,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",296,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4705,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1872,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",279,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5391,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",878,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6205,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1766,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",110,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",85,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2246,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",139,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2318,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7043,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2891,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",464,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3870,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1553,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2374,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1175,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1069,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2171,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",904,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1753,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",416,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1818,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2466,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1201,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",57,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",594,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",378,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2959,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",187,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3677,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2172,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15777,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",673,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",101,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",528,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",113,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1224,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",44,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",23,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",185,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",958,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7980,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",899,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3023,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",66,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",690,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",9998,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",629,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6126,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4044,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10107,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2883,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",109,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",942,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5478,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",191,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",432,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8007,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16788,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4037,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3911,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",35,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2090,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",205,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",154,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2604,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",91,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4802,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5183,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",77,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5455,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",172,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1603,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1985,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6131,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",51,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5048,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4215,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",873,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",34,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14893,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6830,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7888,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19216,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4037,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",94,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",113,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25354,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",395,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",285,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1270,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",621,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",127,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",427,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",105,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11902,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4909,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",135,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4423,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13854,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",20846,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1161,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2152,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6886,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",203,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16594,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5738,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4310,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",160,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2126,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",421,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2196,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2075,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",84,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",73,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2156,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1990,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",91,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1769,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3481,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6516,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",696,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9831,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",88,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4573,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2514,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7170,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5175,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7530,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5844,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1301,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",32725,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",12160,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3039,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2644,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1096,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3387,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",54,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",357,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",119,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11002,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7015,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16131,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",78,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3031,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13452,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",137,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2647,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",668,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",143,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3810,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",718,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2737,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13086,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3835,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",159,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1301,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",541,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26870,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",117,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",203,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",643,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2270,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",123,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6032,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3620,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14675,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",110,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",119,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2007,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",621,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4770,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10068,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",73,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",244,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",202,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2608,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1868,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",138,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1329,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",52,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",78,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2534,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",723,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",419,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2257,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12377,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",48,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8463,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5212,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3719,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",59,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4763,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",78,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",174,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2604,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2808,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4299,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8408,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4802,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",54,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",941,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",143,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",157,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3534,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11103,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",243,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",191,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",69,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4850,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",279,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11770,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",6830,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",36,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",439,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",155,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",100,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",273,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3240,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18633,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4037,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",308,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4181,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8521,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",567,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5212,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3818,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3719,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7527,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",72,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",26,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3858,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6212,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",285,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1328,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",45,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12689,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2067,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",786,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6770,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",233,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5225,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2347,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10155,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",40,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1971,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4480,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8626,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",77,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1312,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",351,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5219,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",42,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",418,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2479,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",459,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1117,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",115,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",291,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",275,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",59,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2747,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1249,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",639,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1341,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1478,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",733,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",340,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",129,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",996,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",139,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",609,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",100,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3010,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8178,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1971,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1352,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1805,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1758,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1024,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14750,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3878,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1336,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",96,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2198,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10359,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",185,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",37,"","","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13580,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",683,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",19222,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1686,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",122,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",170,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1442,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",345,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2975,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2721,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3482,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1108,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1948,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",185,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",216,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",1300,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",66,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",142,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4065,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3648,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3169,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1255,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3618,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1087,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",184,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4163,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2206,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",786,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",396,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1623,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3555,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7683,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3763,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",673,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",996,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2198,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",603,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",613,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1134,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2176,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1735,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1768,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4978,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",371,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4521,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",492,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4197,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8797,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7758,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",87,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",115,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5406,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",282,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2984,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",907,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",56,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",22,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",100,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1469,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",648,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4953,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",57,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",983,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5540,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2156,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",556,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4203,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5202,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",218,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3729,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",809,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",432,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1222,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",60,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",1047,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1995,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",108,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",153,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2490,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2357,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",723,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",42,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",157,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",351,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7464,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2498,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19883,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",650,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",44,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",808,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",869,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",334,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",556,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",62,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1758,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5177,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10425,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",339,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1043,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1351,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",81,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1469,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26269,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10458,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1916,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",273,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",121,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",134,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",317,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2358,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",64,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",482,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4871,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",293,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",110,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",696,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1623,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1067,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",79,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4773,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1079,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",546,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",186,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1762,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",286,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",893,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",953,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2173,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",27,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",329,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",812,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",309,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2448,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",49,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2785,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3539,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1687,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",688,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",922,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",129,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",922,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",129,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1361,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1638,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",306,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",159,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",320,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",86,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1104,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",273,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1551,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3800,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1734,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",310,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",36,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",58,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",752,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",172,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",203,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",148,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",121,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",129,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",592,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",183,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",33,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4461,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",74,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12751,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8671,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",421,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",75,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1059,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",330,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",423,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1834,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",152,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",87,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",639,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1877,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1042,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",133,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",758,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",58,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",686,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",195,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2244,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2889,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1104,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2068,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",626,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1718,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3800,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",46,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",625,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1146,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",46,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11362,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",55,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",202,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",452,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5859,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1279,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2415,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3326,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",354,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",916,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",423,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2480,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",346,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2325,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",626,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",558,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",79,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",133,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",73,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",738,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3778,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",439,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4871,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5062,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",63,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",55,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1834,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",736,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1275,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5859,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",924,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",106,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",689,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",31,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",231,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",696,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",72,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",31,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18828,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5154,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2480,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1146,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",854,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12984,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3084,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8171,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1133,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",724,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1117,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",944,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",472,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11960,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",261,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",140,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5826,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1601,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",157,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",305,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",532,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3243,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9339,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",567,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1081,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",753,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",567,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1867,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",40,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",691,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",161,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",494,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",697,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",468,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1236,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2084,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",446,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2736,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2306,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2252,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2672,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",509,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",213,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",893,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1493,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2672,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",18497,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1227,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4722,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3166,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",484,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1305,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2883,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",209,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",633,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",591,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",839,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1138,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",343,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",317,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1479,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",786,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",79,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1779,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",565,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3154,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",328,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3467,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14870,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2505,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1000,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2619,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1138,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",592,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",135,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",475,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5058,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1108,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",301,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",255,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",275,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2786,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",646,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",156,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",19047,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3444,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",356,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",370,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",565,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",732,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1452,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",475,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",151,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4413,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",674,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5700,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",194,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2864,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",740,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",301,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1268,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5134,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",34,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",134,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1081,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",151,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",973,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1192,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3540,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1506,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",103,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",506,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",75,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",641,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6266,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",577,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1132,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",24065,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",674,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",499,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1497,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1413,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1479,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",967,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",389,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1673,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",221,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12105,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9708,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2236,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10422,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",562,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",288,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1500,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2904,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",25,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",633,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3154,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6126,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",207,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3708,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3708,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2372,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3727,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8206,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",376,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1584,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",255,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1577,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",30407,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2807,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1397,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",85,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",351,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",237,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3027,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",376,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1631,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",71,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",47,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6768,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",717,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",177,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2820,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6997,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9481,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",208,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",62,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2737,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",824,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4709,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",750,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",276,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",55167,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",796,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10514,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",220,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2002,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",13472,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3780,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",127,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",818,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",185,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",163,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1578,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1304,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4399,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",832,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",7593,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8405,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",66,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",46,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",461,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1841,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1481,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",606,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",77,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38892,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",1089,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4824,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",844,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",208,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3582,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3815,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5261,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",39,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",750,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6938,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",8191,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11007,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3155,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7593,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",493,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1250,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1312,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",93,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",932,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",22354,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2701,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",376,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",340,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",22145,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",21265,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",156,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",631,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",102,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",838,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1082,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",142,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",796,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",296,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2018,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",59,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",618,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",824,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",561,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2596,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4997,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2191,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4837,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",16397,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2003,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",159,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",847,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6686,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",314,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6393,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",109,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",468,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",156,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",258,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",718,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",6768,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",252,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",793,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6137,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",82,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3648,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",122,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1744,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",44499,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",647,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1268,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4554,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1698,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26911,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3576,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",45,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1432,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",43,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2659,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",717,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",107,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1268,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",1650,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",718,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2129,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",487,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6244,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",316,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",545,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",114,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",146,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2367,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1190,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1101,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14502,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3830,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",14361,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1218,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5121,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",75,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1330,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",136,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26917,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",548,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",1134,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3259,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4484,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2585,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15905,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",559,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",47,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",25,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8251,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1397,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",35,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",255,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",66,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",864,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8191,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2480,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1135,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",142,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2385,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3155,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5779,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",462,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6475,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",201,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3362,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7159,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1448,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",644,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",250,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",16172,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5710,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",660,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",652,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2384,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3808,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",52,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2003,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",786,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",301,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3935,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",28250,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1611,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",31634,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3108,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1513,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1339,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",282,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",78,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",220,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1017,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",767,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",319,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3600,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",178,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",617,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3390,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2933,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1744,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",295,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1427,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3182,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19367,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",797,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2292,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",445,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",286,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6418,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",602,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",125,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1422,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7104,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",891,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1288,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",516,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",10281,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",530,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",132,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6180,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14028,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",14469,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1524,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5164,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3597,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4364,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",463,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8980,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",660,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",76,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5636,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10634,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",945,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",478,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3850,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7365,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",103,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3133,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13281,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3817,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1744,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",63,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",134,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",12258,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5594,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7025,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",23424,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",10281,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",1521,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",130,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3804,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1654,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4915,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",279,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19086,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",9181,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",69,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25672,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4473,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1768,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",62,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",7316,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",34,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",130,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3512,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",424,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4272,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4255,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6585,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",50,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",583,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",195,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",71,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2627,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2973,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",119,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2973,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",41,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1849,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6674,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6525,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",724,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15462,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",53,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",13183,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5594,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",938,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",187,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",248,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",219,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",43,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",974,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",114,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1064,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1605,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",8918,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",862,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3597,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",776,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5197,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",283,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5719,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6664,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",602,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",379,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",46,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",33557,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3635,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5197,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",19137,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2625,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",249,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",75,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",530,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",96,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5472,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",1324,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",45,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4646,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7486,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",275,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3259,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",75,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",142,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",75,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",29220,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1861,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",143,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",70,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",686,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2951,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2181,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",699,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6732,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",304,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4632,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1527,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",875,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2339,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",94,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38453,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",65,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",171,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6570,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1148,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2675,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2646,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1511,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15766,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",97,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",80,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8764,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",171,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",6664,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13758,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",241,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",142,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",14141,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",9495,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",670,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",120,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1975,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",224,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1139,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",819,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",32768,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",456,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2505,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",9692,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",12477,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",164,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",17951,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",138,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",172,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",141,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",87,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6175,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5701,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13802,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",78,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5569,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1159,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3997,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6599,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",1181,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",10954,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",408,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6345,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",863,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",166,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4092,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",313,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1528,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2234,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5153,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",17031,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6820,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3415,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",58,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",57,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9848,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3027,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",6175,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2946,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",210,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5683,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",47,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2411,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2793,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",64,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7530,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2030,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",25,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",381,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",1366,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",117,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",341,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",104,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",234,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",723,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",641,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",501,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28792,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3997,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",280,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",90,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",89,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5153,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",424,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22563,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",9692,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1178,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",393,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3093,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1057,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",166,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5096,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",173,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",206,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1516,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",865,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",78,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",61,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",313,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",441,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3291,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1843,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",138,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",36699,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6290,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1252,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",154,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5802,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1656,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15737,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",77,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2975,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",100,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6132,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",153,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",117,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2579,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",848,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",60,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20798,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",680,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",89,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9160,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",65,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1218,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",152,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4020,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15485,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",87,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4752,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1428,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",511,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1178,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",162,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",426,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4480,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",97,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11394,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",839,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",250,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",41940,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3836,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",21142,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",117,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5152,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1161,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6391,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",75,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1511,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",167,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1161,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3157,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6237,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9504,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",257,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",279,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1975,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3169,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",861,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",206,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",704,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",140,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",42,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",17611,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",251,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",577,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8761,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",110,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2024,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",134,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",58,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",110,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4211,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",515,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1549,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3029,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2657,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",456,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",100,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2534,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",125,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2905,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",93,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2239,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",226,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",130,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",456,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5219,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",214,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3214,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",58,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",832,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",76,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7025,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",828,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4854,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1932,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4009,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2192,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1180,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",538,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1613,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10144,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",125,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2239,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1572,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6509,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2657,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",769,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",175,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",153,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4896,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",366,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3152,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",549,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2764,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1255,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1430,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",705,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1069,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",538,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1636,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1042,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",98,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1361,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3141,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5837,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2392,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6765,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10720,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",607,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",56,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",84,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",986,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",421,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",517,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",153,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",819,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2527,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2320,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2005,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1270,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",460,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4974,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1265,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",456,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10464,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",965,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5813,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",658,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",82,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1667,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",871,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",186,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",131,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",998,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2808,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1335,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1796,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2819,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",475,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3141,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3870,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",828,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1137,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",791,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4651,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3485,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",810,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7621,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1475,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14386,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",261,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",32,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1002,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",47,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",82,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",128,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",613,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",456,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",29,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",549,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",641,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",58,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",460,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7538,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",355,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",248,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1005,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",82,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",274,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",820,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1073,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1667,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",487,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",58,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",155,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",871,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",389,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8400,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",16152,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3187,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12465,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9382,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",12115,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",10452,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",835,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5036,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6128,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7544,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2128,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",28519,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",12115,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2554,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4583,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",990,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",22426,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",862,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",33146,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6739,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9029,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4013,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",140,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4544,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",11259,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10837,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",80,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",55,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",84,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",16417,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",16689,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",364,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",39813,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",12738,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",326,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5526,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2369,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1277,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8300,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",21338,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",15769,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",61665,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",278,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3150,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",12738,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",10453,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1504,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2819,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",43405,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4177,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",56,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5373,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4823,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",30637,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",725,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",55,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",17825,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11219,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3144,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3424,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3499,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",524,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",10971,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",1098,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",112,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1200,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2279,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9352,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7080,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",10810,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1206,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12096,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7388,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",20353,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",88,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",454,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2964,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",174,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",23743,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1953,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",750,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",8593,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",44,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1995,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",17158,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8552,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",1416,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2861,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5987,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",2136,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6910,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",2738,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10143,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4359,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",166,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",89,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3766,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",10452,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10119,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",929,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6417,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8959,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23190,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",999,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",4154,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26716,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2299,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",476,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5526,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4638,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5417,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17841,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5390,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2416,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",476,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",174,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",20478,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",280,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",555,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13891,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",87,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1277,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",9900,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10998,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5887,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",734,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",64,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3424,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",9221,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11589,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3144,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",7080,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3766,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1475,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",26295,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5426,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2018,2018,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",73,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",42,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",26285,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3478,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1731,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",95,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14833,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",133,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",348,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",66,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",837,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9536,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",375,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",41,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1545,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",129,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1258,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3015,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7985,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",324,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",31,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5701,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",824,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",310,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",620,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1492,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",817,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1795,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13457,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5404,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1462,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",208,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5331,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",824,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1455,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3778,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",34,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1462,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",694,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",466,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",136,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1645,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",613,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",21,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7459,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",353,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",60,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1338,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",919,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2537,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",709,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4980,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",156,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2532,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",134,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4596,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",77,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19886,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1873,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",78,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1011,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3669,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3845,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5223,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",149,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",34,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",984,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1449,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8053,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",503,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2133,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",333,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",69,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",581,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",736,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",45,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",798,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3749,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1317,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",194,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",304,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14600,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",941,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3015,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1322,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",416,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",424,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1439,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2799,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",59,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10350,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3624,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2845,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",263,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6193,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",64,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",984,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",45,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1624,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1351,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2537,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",110,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",153,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",409,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",109,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",357,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3845,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",834,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",173,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",709,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1492,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3051,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",91,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",27,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",757,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",87,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",233,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2971,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",112,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3131,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4408,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4178,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",813,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",40,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11017,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",944,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",183,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",833,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",184,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",287,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",336,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6615,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",449,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",298,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1693,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",87,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",797,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",129,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3066,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1951,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1455,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",99,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2662,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9059,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",419,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1798,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3127,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1754,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",37,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",841,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2765,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2516,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3340,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",93,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",615,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1413,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5552,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",87,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4669,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6263,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11121,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6040,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2344,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",248,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",589,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1478,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2552,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",98,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3462,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",378,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",299,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6014,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2457,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",262,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",529,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10329,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",109,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",86,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14511,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",326,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",797,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2638,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8037,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",111,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",800,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",264,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",92,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3222,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",295,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",601,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",34,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",44,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7335,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",3462,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",178,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5748,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",990,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8384,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1534,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",98,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",731,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",29,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",45,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5049,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2526,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5880,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2891,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4936,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",67,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4142,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",519,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4059,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",365,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",84,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",83,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2973,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2240,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",119,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6478,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",4936,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",426,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",346,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",483,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",56,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3222,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",941,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",111,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",146,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5583,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",438,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5780,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",29,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",52,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",564,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6624,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1659,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",41,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8805,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",139,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",65,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2629,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",84,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",269,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1015,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",40,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",117,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",131,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",847,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",75,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6084,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",767,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6794,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",960,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",626,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",119,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2680,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",328,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7475,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4337,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",329,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",378,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",5101,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",314,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8505,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",97,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7716,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5547,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",438,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",264,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4066,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",231,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",189,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5101,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",85,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",426,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",498,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",626,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5447,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15980,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",160,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",269,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",117,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",546,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",131,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4815,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",792,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",40,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",401,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",85,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1387,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",149,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",85,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",85,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3995,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",143,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",12061,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2549,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",755,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2552,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2260,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",263,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",173,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",244,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2883,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",47,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",124,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6606,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3358,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2782,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3269,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",301,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",99,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2488,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",189,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2526,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",329,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1446,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",185,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",834,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",65,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",144,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6242,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15753,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",53,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1336,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11655,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10316,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",58,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",423,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2018,2018,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2997,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2575,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1232,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2865,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",217,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",526,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",755,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",966,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",311,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2409,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",134,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",58,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",583,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",559,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",391,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",438,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",203,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",122,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",86,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",616,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",220,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1912,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1304,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",618,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",886,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",376,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1115,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1658,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1907,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",2315,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6282,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",417,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",216,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",193,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",105,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",48,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1054,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",544,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",131,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2419,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",569,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2322,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",573,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",190,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",241,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",737,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1837,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",64,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",63,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2685,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",380,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",350,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",318,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",805,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1282,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",990,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",318,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3156,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1304,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",195,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",960,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1400,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",994,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3192,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",110,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4924,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",402,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",28,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3347,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",95,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",778,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2315,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1759,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",342,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1364,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",95,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1026,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5007,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4848,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",190,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",349,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",136,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",871,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1888,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",58,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",358,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3017,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1624,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1691,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",52,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",241,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",380,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",886,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",75,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",954,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4695,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3306,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"ALC","ALC6_0","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",498,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",498,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",746,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6503,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"AK","Alaska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"AST","AST4_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",203,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",89,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",212,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",420,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",1115,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3383,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",186,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",111,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",207,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2590,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5298,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",5575,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2941,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1595,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1811,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4269,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3797,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1408,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",459,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",711,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",748,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",82,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",336,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",34,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",126,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",267,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3445,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",22,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",139,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2179,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2075,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",553,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5441,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3901,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1584,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1416,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17699,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1679,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",591,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",65,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",192,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",109,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",28,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13436,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",700,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9248,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1561,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",328,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1148,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4277,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10201,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",92,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2574,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2029,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4025,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4720,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2807,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1074,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",256,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4912,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2184,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",728,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",844,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1186,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",85,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2284,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4647,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",56,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1104,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",80,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",53,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",261,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",387,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",119,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3095,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8669,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6733,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11390,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",40,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",484,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5083,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",148,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",149,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",398,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",284,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",74,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13222,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",288,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",176,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",88,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",66,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",148,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3203,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",74,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10851,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2032,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17086,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3095,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",695,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",495,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7240,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1190,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",48,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",78,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2545,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1281,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10878,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2003,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",229,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8504,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2382,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",136,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2621,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",279,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",256,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",141,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2979,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",29,"","","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2304,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",395,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",557,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1242,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",222,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",207,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7739,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3555,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",74,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",195,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",80,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",90,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",255,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2079,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",471,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",144,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7146,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",36,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",61,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6140,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",423,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",35,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",59,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",409,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",320,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3046,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",236,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5795,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5355,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",34,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7420,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2708,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",2719,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",511,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1759,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6144,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3182,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2237,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1746,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9242,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",286,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",171,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",25,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",46,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",117,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",659,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",126,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",74,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7033,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",52,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",244,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6208,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",95,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1400,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",40,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",201,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6881,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2172,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2851,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5571,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",58,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",29,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",843,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",79,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6716,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",12587,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3695,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",160,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1149,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1143,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",59,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3142,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",75,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",2219,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3453,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",683,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",644,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",77,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1410,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",464,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",245,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",838,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",713,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",181,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1735,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3589,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2909,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3290,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9195,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5170,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3960,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",26,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7844,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",2010,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",52,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",831,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",179,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"OVC","OVC5_0","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1371,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",377,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",678,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",76,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",111,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"OVC","OVC5_0","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",290,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_3","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",210,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",204,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1395,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",43,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_1","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",181,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",758,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13448,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",305,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"CA","California","NVSS","Alcohol","Chronic liver disease mortality","Number",93,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"ALC","ALC6_0","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1686,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",436,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_1","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",50,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",641,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",281,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CKD","CKD1_0","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",422,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",47,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2073,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",400,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_2","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",205,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4135,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"OVC","OVC5_0","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10054,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5428,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_2","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",62,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",53,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_2","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"COPD","COPD1_1","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"ALC","ALC6_0","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",47,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",283,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_1","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",296,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_2","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",189,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2018,2018,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",61,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Alcohol","Chronic liver disease mortality","Number",183,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"ALC","ALC6_0","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",87,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2018,2018,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",227,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4768,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_2","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",515,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7626,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",71,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",408,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_2","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",99,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4509,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1051,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_3","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1256,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_5","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3287,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",27,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"DIA","DIA1_2","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",115,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_2","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"AZ","Arizona","NVSS","Alcohol","Chronic liver disease mortality","Number",1217,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"ALC","ALC6_0","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1874,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",68,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CKD","CKD1_0","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3567,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_1","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"COPD","COPD1_1","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AK","Alaska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"DIA","DIA1_2","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2263,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_5","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1118,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_1","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4453,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_3","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"AZ","Arizona","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"AST","AST4_1","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AL","Alabama","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1052,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"DIA","DIA1_1","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",848,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_5","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"CA","California","NVSS","Asthma","Asthma mortality rate","Number",377,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"AST","AST4_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",47,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_2","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AR","Arkansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"AST","AST4_1","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"AL","Alabama","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1910,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CKD","CKD1_0","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"AST","AST4_1","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"AL","Alabama","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"OVC","OVC5_0","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"AZ","Arizona","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1820,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"COPD","COPD1_1","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",101,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"DIA","DIA1_2","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",163,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_3","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2019,2019,"AZ","Arizona","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2111,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CKD","CKD1_0","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"AR","Arkansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"COPD","COPD1_2","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",47,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_5","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",310,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",86,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1227,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3229,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",301,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",34,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",580,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1205,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",107,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",33,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3752,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",42,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3231,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",53830,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1240,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7463,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",62394,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6543,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",186,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",408,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",504,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",25593,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1313,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1088,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1625,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",48,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2121,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1990,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2197,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",14303,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",21914,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",292,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4679,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",528,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",245,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",195,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10691,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2544,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2647,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",49236,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",18646,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",68,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",465,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",109,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3740,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2381,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3215,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",12739,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",793,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",41,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",837,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",26,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1297,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",622,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14649,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",169,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1768,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",7356,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",44,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",334,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2311,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",62,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1629,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2716,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",188,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",10510,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4497,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1269,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4620,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",292,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",37,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",45,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6300,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",57,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",627,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",23,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",833,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",45,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1200,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1345,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5680,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3769,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",21,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",164,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1238,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",16851,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7354,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5333,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1619,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",367,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9380,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",480,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",820,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5105,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",838,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",12582,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",262,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1093,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",46102,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",319,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",32949,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",66,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",938,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",12350,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",163,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1489,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3812,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8050,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",13243,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",783,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",65,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18437,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",119,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22558,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5585,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",64,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",71,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",40,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1618,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15710,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",154,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",146,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1175,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13579,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1253,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7762,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",34690,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2179,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",282,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",538,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",121,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7537,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2971,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6347,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",461,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",126,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",48,"","","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1155,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",319,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",39575,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",9548,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",47,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",197,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10577,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",582,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2455,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",101,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",57,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",743,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4252,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3136,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4494,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",329,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",31,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4590,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",392,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",13300,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",9620,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",787,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",102,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",997,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",54,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2446,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2935,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",271,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",87581,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",86,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",64,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",64,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",138,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5455,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3143,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1290,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",960,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",186,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",98,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",30799,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",443,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",100,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",74,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",28,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9837,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",572,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6039,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",457,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6470,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1375,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1719,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2963,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",270,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3167,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",510,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",183,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2709,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2476,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",263,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",15693,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5717,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",173,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",668,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",90,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3510,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",507,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",9159,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_1","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",206,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1241,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",19164,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3363,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_5","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_1","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",27704,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4790,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",179,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",125,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_2","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5127,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1969,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4110,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",46,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",47,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_3","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",213,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1953,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Asthma","Asthma mortality rate","Number",43,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"AST","AST4_1","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3602,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",118,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"DC","District of Columbia","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"ALC","ALC6_0","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3758,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",158,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",28,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",484,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",765,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.036871 38.907192)",11,"OVC","OVC5_0","NMBR","RACE","API",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6473,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_2","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",259,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_1","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8759,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",832,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",36563,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_3","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",333,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"CO","Colorado","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"AST","AST4_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",55,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CKD","CKD1_0","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_5","NMBR","RACE","AIAN",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1431,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",41479,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",288,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",174,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",58,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"COPD","COPD1_1","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",70,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1975,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2472,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CKD","CKD1_0","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",767,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DE","Delaware","NVSS","Alcohol","Chronic liver disease mortality","Number",98,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"ALC","ALC6_0","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",242,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1990,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4935,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"COPD","COPD1_2","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",264,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_1","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1187,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"CA","California","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",268,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"DIA","DIA1_2","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"AST","AST4_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2843,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",24559,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"OVC","OVC5_0","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",736,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"OVC","OVC5_0","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",50,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_5","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"DC","District of Columbia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"AST","AST4_1","NMBR","RACE","WHT",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Alcohol","Chronic liver disease mortality","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"ALC","ALC6_0","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",418,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",528,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_3","NMBR","RACE","BLK",-77.036871,38.907192
2019,2019,"CT","Connecticut","NVSS","Alcohol","Chronic liver disease mortality","Number",342,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"ALC","ALC6_0","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",191,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CKD","CKD1_0","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CT","Connecticut","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"DIA","DIA1_2","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"CT","Connecticut","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"COPD","COPD1_1","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2019,2019,"CA","California","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",23810,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CKD","CKD1_0","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.036871 38.907192)",11,"CVD","CVD1_2","NMBR","RACE","AIAN",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",144,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_3","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_1","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",457,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_1","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"CA","California","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1858,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"COPD","COPD1_2","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CO","Colorado","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",49,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"DIA","DIA1_2","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-77.036871 38.907192)",11,"DIA","DIA1_2","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",98,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",336,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_2","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",583,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_2","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"CO","Colorado","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",136,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"OVC","OVC5_0","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5450,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_1","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",218,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1197,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_5","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"COPD","COPD1_2","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",193,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3568,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",445,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",108,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",172,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",510,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1111,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",431,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4006,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2841,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",9675,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",180,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7927,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",9920,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",191,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1973,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",920,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1396,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2079,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",610,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10655,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17430,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",631,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1275,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",26323,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",13902,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",38,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",199,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",272,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5904,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",390,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",403,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1133,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",648,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",432,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12421,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",14122,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",228,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",65895,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",485,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",462,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",91,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",98,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",11601,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7737,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1285,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",84,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3206,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",723,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",381,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7819,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",741,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",419,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",2013,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1667,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",20821,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7473,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",17330,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",147,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5694,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1820,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",133,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",10102,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4086,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",271,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3928,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1716,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",3192,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7002,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",652,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",80,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",48,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",47144,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",105,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",193,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",156,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",426,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",1230,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",149,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",145,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",517,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",97,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22163,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4539,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6116,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8888,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1469,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",462,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",126,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1607,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",35060,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",683,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",170,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",211,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",372,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13563,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7723,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1774,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",303,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4700,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",941,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",104,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",405,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2503,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",247,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13467,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",177,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2006,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",34582,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1245,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3156,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",423,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",66,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",318,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5773,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6480,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",63,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",106,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",166,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7228,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2965,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4059,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",153,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5595,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",54,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",245,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",118,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6351,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1071,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2195,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",57,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",34,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1507,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",122,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3387,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3580,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2947,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2274,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",67,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",23863,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",807,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1035,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",45,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4364,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",927,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",62,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",12071,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",51,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",304,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",815,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",11711,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2619,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2594,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",59,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",269,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",267,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2368,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7880,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1199,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",441,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",124,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",47,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2118,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",604,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",275,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",131,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",457,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6518,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",78,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",260,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",40,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",645,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1945,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",17344,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",69,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2343,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2476,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",299,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",104,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",594,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3883,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9117,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",41,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11340,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7934,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4771,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",499,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1331,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1990,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",463,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",62,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",20153,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",19543,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2500,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_5","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",34,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_2","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",50,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_1","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1468,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11518,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",28,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_1","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",894,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","RACE","API",-157.857749403,21.3048504350004
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",75,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",8129,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",849,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",184,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",755,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",688,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_3","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",182,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","AIAN",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",199,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",752,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",12345,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",31313,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1690,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_2","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6171,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CKD","CKD1_0","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Alcohol","Chronic liver disease mortality","Number",81,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"ALC","ALC6_0","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1116,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",485,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_1","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5527,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5189,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_2","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",479,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",665,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",326,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_1","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2838,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_1","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",25984,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22515,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9456,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",56,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",873,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"COPD","COPD1_2","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2854,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_3","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",491,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2838,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4594,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",323,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_2","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",463,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_1","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2053,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Asthma","Asthma mortality rate","Number",115,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"AST","AST4_1","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",24834,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",13784,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1071,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"OVC","OVC5_0","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11229,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"GA","Georgia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"ALC","ALC6_0","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"DIA","DIA1_2","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",64,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",48145,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_1","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",125,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"COPD","COPD1_2","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",120,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_3","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",683,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CKD","CKD1_0","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"DIA","DIA1_1","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_2","NMBR","RACE","AIAN",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",721,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"OVC","OVC5_0","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","RACE","AIAN",-157.857749403,21.3048504350004
2018,2018,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",136,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",783,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",200,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_5","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"FL","Florida","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CKD","CKD1_0","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",399,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"HI","Hawaii","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"AST","AST4_1","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"GA","Georgia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",82,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"DIA","DIA1_2","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"HI","Hawaii","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",835,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"DIA","DIA1_1","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",324,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CKD","CKD1_0","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"HI","Hawaii","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",264,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"COPD","COPD1_2","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",40,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_5","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Asthma","Asthma mortality rate","Number",130,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"AST","AST4_1","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",63,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_3","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",462,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_5","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"FL","Florida","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",36637,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"OVC","OVC5_0","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"GA","Georgia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",19063,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"OVC","OVC5_0","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28,"","","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_2","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"GA","Georgia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1341,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"COPD","COPD1_2","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"FL","Florida","NVSS","Alcohol","Chronic liver disease mortality","Number",1179,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"ALC","ALC6_0","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12243,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1001,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",102,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7235,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",34322,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4152,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7505,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",54,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4674,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",498,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1544,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4254,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",41,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",25,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",897,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11866,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",56,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1412,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4854,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8946,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",333,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1108,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1871,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",696,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2851,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",530,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6895,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",48,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",20,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4002,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",926,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3496,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",493,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",1071,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7719,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",64,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",9541,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17597,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4006,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",393,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2141,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1396,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3825,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3194,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",91,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",754,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",489,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",35,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1121,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",37,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",80,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",62,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",30,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",38,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",103,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",591,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2091,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",351,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",28,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",600,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5071,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4583,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",322,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1527,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",103,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",978,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",72,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9295,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2932,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",542,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",77,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1339,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",841,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13824,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",19962,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3325,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5113,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",19774,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1779,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",813,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",156,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",607,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",91,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1371,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1783,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3555,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",298,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",226,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",56,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12889,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2374,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3701,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1089,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7255,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16725,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6024,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1580,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1570,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",644,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",51,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",53,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",73,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",139,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2476,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",286,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26091,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",124,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",935,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3552,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1015,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",88,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",38,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3061,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",940,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",599,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",93,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4509,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",76,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",8239,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",526,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",22,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",21,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1807,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25690,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1666,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1601,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",688,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",27,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6145,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1076,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","AIAN",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5765,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",77,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1357,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",86,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8512,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",171,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",9737,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",385,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2177,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9657,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5327,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",34,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5058,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",233,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",40,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1916,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",188,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3918,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1200,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4724,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3328,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",1463,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4723,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4275,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",99,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1896,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2598,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2607,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2131,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Alcohol","Chronic liver disease mortality","Number",249,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"ALC","ALC6_0","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_5","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",68,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",236,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_2","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Alcohol","Chronic liver disease mortality","Number",53,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"ALC","ALC6_0","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",46,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CKD","CKD1_0","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3953,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",12348,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",895,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",595,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_1","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",166,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",180,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",683,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_5","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",910,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_1","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",971,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_2","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",94,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",567,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",41,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",28,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",9925,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1387,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1826,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_2","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1704,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_2","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2313,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"OVC","OVC5_0","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",213,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4938,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"OVC","OVC5_0","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1717,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_3","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",933,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",256,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",66,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3567,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Alcohol","Chronic liver disease mortality","Number",357,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"ALC","ALC6_0","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",219,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",517,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3964,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",185,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"COPD","COPD1_2","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"ID","Idaho","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",478,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"COPD","COPD1_1","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1550,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1864,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"OVC","OVC5_0","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"ID","Idaho","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"DIA","DIA1_2","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",137,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Asthma","Asthma mortality rate","Number",53,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"AST","AST4_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"IA","Iowa","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"DIA","DIA1_2","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4515,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8425,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"DIA","DIA1_1","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",135,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_2","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2018,2018,"IL","Illinois","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"AST","AST4_1","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4237,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Alcohol","Chronic liver disease mortality","Number",145,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"ALC","ALC6_0","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_1","NMBR","RACE","AIAN",-88.9977101779997,40.4850102830005
2019,2019,"IN","Indiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",130,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CKD","CKD1_0","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2018,2018,"ID","Idaho","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"AST","AST4_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2018,2018,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IL","Illinois","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5976,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CKD","CKD1_0","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1829,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Asthma","Asthma mortality rate","Number",42,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"AST","AST4_1","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"COPD","COPD1_2","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4390,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_3","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1483,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_3","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6153,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_5","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2571,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_1","NMBR","RACE","BLK",-114.363730042,43.6826300050005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",195,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2461,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CKD","CKD1_0","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4903,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_1","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"IN","Indiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4818,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"COPD","COPD1_2","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1176,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1100,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2487,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7475,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",349,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",994,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",507,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",318,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5866,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",27,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6487,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",97,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",186,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",363,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1438,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7618,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",965,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3895,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2357,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2026,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",199,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2843,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",161,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",803,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5944,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",66,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3992,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",373,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5454,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",162,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10168,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",543,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",85,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1523,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2593,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",54,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",292,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",95,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",170,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3160,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",51,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1459,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5517,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",738,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3195,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1615,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",71,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6163,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1299,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1453,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1642,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",413,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7693,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9446,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",43,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1628,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",83,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",630,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1732,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",22,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",304,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",262,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",146,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",29,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1303,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",68,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",243,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4431,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",28,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",142,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5110,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9466,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2201,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6140,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",40,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6740,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",255,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3297,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",220,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4032,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",44,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",80,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6519,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",166,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1395,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3785,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2108,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6344,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1461,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4050,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4798,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7615,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1622,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1706,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5033,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2106,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",63,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",292,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7358,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3805,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3652,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",84,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",631,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2386,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2000,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7801,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3454,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6909,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6665,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",78,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2296,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2169,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",853,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",74,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",43,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",28,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",37,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3361,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3432,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",93,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",202,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6089,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",72,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1451,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",48,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",68,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",21,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",80,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",123,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1329,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",154,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8037,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",34,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12746,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4233,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",23,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7188,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3465,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14335,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5822,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",554,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",448,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19413,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",133,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4833,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",143,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",42,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",207,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1873,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",54,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1000,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1092,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",454,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",44,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",927,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",509,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",746,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10742,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",87,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",17368,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",54,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4016,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",130,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1583,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3206,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9911,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10805,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5213,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",133,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4573,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",40,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2100,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10752,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2101,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3346,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",37,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1826,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",106,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",31,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1141,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",448,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",74,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13845,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4521,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_1","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1057,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_5","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",62,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1254,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7815,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7386,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5145,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",281,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4270,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_2","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",26,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",997,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",92,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1106,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13085,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",129,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_1","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",65,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3278,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_3","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",929,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2342,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Alcohol","Chronic liver disease mortality","Number",191,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"ALC","ALC6_0","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11302,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_2","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1115,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9967,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",696,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4142,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_1","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",30,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2833,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2995,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"KY","Kentucky","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9688,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"OVC","OVC5_0","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",36,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2970,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2019,2019,"LA","Louisiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4005,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"OVC","OVC5_0","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_5","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4935,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CKD","CKD1_0","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3043,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_3","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2110,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6965,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_1","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3304,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_1","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1908,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_5","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",536,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","RACE","AIAN",-86.1499601939997,39.7669104520004
2019,2019,"MA","Massachusetts","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"ALC","ALC6_0","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2177,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3039,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_1","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",47,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",165,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"DIA","DIA1_2","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",301,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_1","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",391,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"OVC","OVC5_0","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2354,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CKD","CKD1_0","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2018,2018,"KS","Kansas","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"AST","AST4_1","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",23,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Alcohol","Chronic liver disease mortality","Number",129,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"ALC","ALC6_0","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",730,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1519,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",38,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_1","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",696,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"DIA","DIA1_2","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"MA","Massachusetts","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"AST","AST4_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"IN","Indiana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12726,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"OVC","OVC5_0","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_5","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"KY","Kentucky","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"AST","AST4_1","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","AIAN",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"DIA","DIA1_2","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"KS","Kansas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",32,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"DIA","DIA1_2","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"LA","Louisiana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2899,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CKD","CKD1_0","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"KY","Kentucky","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"COPD","COPD1_2","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_3","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1580,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"KS","Kansas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",31,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"COPD","COPD1_2","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",705,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",47,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_2","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3042,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_3","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",596,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"KY","Kentucky","NVSS","Alcohol","Chronic liver disease mortality","Number",750,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"ALC","ALC6_0","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"LA","Louisiana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1654,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"COPD","COPD1_1","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"LA","Louisiana","NVSS","Asthma","Asthma mortality rate","Number",55,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"AST","AST4_1","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",329,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_2","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14555,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_2","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",366,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2355,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7605,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3471,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",235,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7128,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1178,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3763,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",53,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2073,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",505,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",93,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",27,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",539,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",210,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",91,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",158,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1737,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8476,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4793,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3372,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",60,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5194,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",195,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2357,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2464,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",102,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",62,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1640,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",120,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5798,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",81,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6438,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",135,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",64,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",69,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1599,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11246,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",921,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",218,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",250,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",351,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",574,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",93,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",173,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",201,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2283,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",227,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10439,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",991,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7798,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",963,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11770,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",44,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",313,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",53,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",97,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1479,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",34,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2512,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",131,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",141,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1964,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1661,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1237,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",967,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",516,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",194,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1768,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4148,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",56,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1625,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16687,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6022,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",115,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",230,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3177,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13715,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3450,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",142,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4830,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4775,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2881,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",53,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",57,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",72,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3836,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",37,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",277,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",363,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",921,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11761,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6279,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18154,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",139,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1773,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",429,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",63,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3472,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4695,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5136,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7952,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3764,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",752,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",51,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",380,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2310,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",1181,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",108,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3795,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",281,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",22,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",104,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",46,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2712,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2081,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",21113,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3076,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",881,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",985,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",100,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",526,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1137,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",634,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1812,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",951,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7731,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",116,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",53,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",34,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2664,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5789,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",296,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",64,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",54,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2102,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",789,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5655,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",45,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5178,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2412,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4296,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",61,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",993,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",98,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",652,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",411,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3001,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",410,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",62,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8796,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1317,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4960,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2722,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5580,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2008,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25547,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",777,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10100,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1326,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4123,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1337,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",27208,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",42,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9414,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16036,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",445,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2505,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16250,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",68,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",259,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",152,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2043,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15529,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7771,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10538,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",86,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11938,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2058,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3049,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1561,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",84,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",153,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4396,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",323,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",26,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7071,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5549,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5069,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3604,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",643,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3718,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","HIS",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2339,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",910,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",349,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",948,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4317,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",65,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",78,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4057,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14498,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",556,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",467,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2046,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2339,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9999,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",100,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1795,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",921,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",187,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_3","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1544,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",99,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",309,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",28,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1642,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5705,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11026,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",77,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",32937,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",106,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",50,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13567,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"OVC","OVC5_0","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3616,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"OVC","OVC5_0","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1284,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",160,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",137,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MN","Minnesota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"AST","AST4_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",479,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",106,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2654,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CKD","CKD1_0","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1300,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4291,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CKD","CKD1_0","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2483,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",481,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5602,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2417,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"OVC","OVC5_0","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6181,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",40,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3717,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1758,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8084,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"DIA","DIA1_2","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",87,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",12011,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_3","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",825,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_2","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2018,2018,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",130,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",213,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5491,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_2","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",68,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",116,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_5","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_2","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2940,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",172,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5541,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_2","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",92,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",103,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"DIA","DIA1_2","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",41,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",329,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_1","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_3","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Alcohol","Chronic liver disease mortality","Number",573,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"ALC","ALC6_0","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",375,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_2","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"MN","Minnesota","NVSS","Alcohol","Chronic liver disease mortality","Number",267,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"ALC","ALC6_0","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2834,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_3","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",222,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",1437,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5003,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CKD","CKD1_0","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5942,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13609,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_2","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",140,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"DIA","DIA1_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5274,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"OVC","OVC5_0","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",686,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_5","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2555,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_1","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",148,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"COPD","COPD1_2","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"MI","Michigan","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"AST","AST4_1","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"MD","Maryland","NVSS","Asthma","Asthma mortality rate","Number",77,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"AST","AST4_1","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"MI","Michigan","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",32,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"COPD","COPD1_1","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_2","NMBR","RACE","API",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_2","NMBR","RACE","AIAN",-76.6092601109996,39.2905809640005
2019,2019,"MA","Massachusetts","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"DIA","DIA1_2","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2019,2019,"ME","Maine","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-68.98503133599962 45.254228894000505)",23,"AST","AST4_1","NMBR","RACE","AIAN",-68.9850313359996,45.2542288940005
2019,2019,"MD","Maryland","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"COPD","COPD1_1","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",69,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_5","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"ME","Maine","NVSS","Alcohol","Chronic liver disease mortality","Number",200,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"ALC","ALC6_0","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",986,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"COPD","COPD1_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"ALC","ALC6_0","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",635,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_5","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"MI","Michigan","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7188,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CKD","CKD1_0","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3868,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_1","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6978,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6055,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",44,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",128,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",43,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",457,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",391,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",50,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1588,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2112,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2297,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",557,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",639,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",82,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2697,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2079,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2409,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2940,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",281,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",46,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1282,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1100,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",70,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2012,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8401,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",638,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",843,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1140,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3608,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1043,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1925,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2503,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",380,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",735,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6723,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",51,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5547,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2365,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",1175,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",64,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",973,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",687,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2454,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",27,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3342,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2587,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16703,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",111,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",266,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",76,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",183,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",50,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4174,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",54,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1711,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7131,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11147,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",57,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2350,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",40,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",65,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",91,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2652,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2999,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",391,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9842,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",385,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",793,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5639,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1176,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",93,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3464,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1071,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1192,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",227,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",125,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",92,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7420,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1386,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",743,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1911,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1749,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1988,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4389,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",20,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15018,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",67,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1641,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",828,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",395,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7869,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",84,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",227,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1317,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1354,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",103,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",707,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",52,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",48,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",82,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4288,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2913,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",58,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",1443,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1918,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",32,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3753,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4134,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",356,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6232,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1049,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",90,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",878,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1566,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",167,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4944,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4003,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12095,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",81,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2756,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",83,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1183,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2290,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7043,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3196,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3906,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",56,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",972,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19120,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1730,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11974,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",647,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",180,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1461,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",27,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1001,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3031,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2182,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",61,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",107,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3699,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",612,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7427,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",21,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",160,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",46,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3184,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",470,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13223,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",360,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",424,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",176,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2171,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",37,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",167,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",29,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5857,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2905,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",52,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",170,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7997,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",635,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",72,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",413,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",189,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7978,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",681,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",963,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2256,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1681,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5441,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5200,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",49,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2126,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",125,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",50,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",51,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",982,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4722,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2760,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6310,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1226,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","API",-109.424420645,47.0665289720005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",94,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",189,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",987,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10081,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2018,2018,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",115,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4258,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4194,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4023,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",30,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9039,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4879,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",462,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4668,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",130,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1364,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3472,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",77,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",716,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",290,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",223,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"OVC","OVC5_0","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",22,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3916,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",61,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4375,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1961,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",36,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3870,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",23,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",802,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",311,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Alcohol","Chronic liver disease mortality","Number",64,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"ALC","ALC6_0","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2573,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"ALC","ALC6_0","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6117,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_1","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",907,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",76,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3479,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",32,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_2","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1541,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",34,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1851,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10583,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_1","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3421,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",44,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_5","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1298,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_3","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",75,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",139,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",126,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",30,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_1","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2018,2018,"MT","Montana","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"AST","AST4_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CKD","CKD1_0","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",67,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1542,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",425,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_1","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",747,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",186,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"MT","Montana","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"DIA","DIA1_2","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8295,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",263,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",358,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_1","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"AST","AST4_1","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",113,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_5","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",32,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"OVC","OVC5_0","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",523,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"OVC","OVC5_0","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"NC","North Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"ALC","ALC6_0","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",41,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",146,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6763,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"COPD","COPD1_2","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4480,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4794,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_3","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"ALC","ALC6_0","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1274,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_2","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",102,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"DIA","DIA1_2","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-109.42442064499971 47.06652897200047)",30,"COPD","COPD1_1","NMBR","RACE","API",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2322,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"COPD","COPD1_2","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2074,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_1","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2557,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CKD","CKD1_0","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",45,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_5","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",230,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_5","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_2","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2685,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_3","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",35,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_2","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4531,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_2","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",108,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_2","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2018,2018,"NC","North Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"AST","AST4_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",136,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_3","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5500,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",49,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"OVC","OVC5_0","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2029,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"DIA","DIA1_1","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",194,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2019,2019,"MS","Mississippi","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"DIA","DIA1_1","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"MO","Missouri","NVSS","Asthma","Asthma mortality rate","Number",40,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"AST","AST4_1","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"MT","Montana","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CKD","CKD1_0","NMBR","RACE","BLK",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"COPD","COPD1_2","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1303,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_2","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"MN","Minnesota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",115,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CKD","CKD1_0","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1657,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",510,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",79,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4834,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",57,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",243,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",39,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",113,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",160,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2108,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",177,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",671,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",59,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",853,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",567,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",51,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",769,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",873,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",598,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4433,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1111,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2464,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2407,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",782,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1483,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1470,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1073,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1806,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13853,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",37,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2392,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",397,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",283,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",149,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",29,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",22,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",395,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",43,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",169,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1910,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",879,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",114,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",103,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4220,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",321,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1342,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10405,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2798,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1008,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",163,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",34,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3958,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1116,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",80,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11276,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1625,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",820,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",50,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",526,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",84,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",992,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8816,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1094,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5184,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",345,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",716,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10604,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",264,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",686,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2668,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",42,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",608,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",134,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3415,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",297,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",102,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",30,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5202,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",94,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",79,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",122,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",91,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",35,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4054,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5269,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",120,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",312,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",531,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",239,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",666,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1877,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",329,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",308,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",93,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",381,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",41,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",119,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",60,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1377,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",307,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4572,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",993,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",195,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",44,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15039,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3331,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",902,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",803,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1451,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",354,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",69,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1045,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2231,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10318,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5225,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7514,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1074,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",109,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",678,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1448,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",556,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",727,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2707,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",705,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",80,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1864,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4748,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9013,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",70,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",126,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",42,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1834,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",688,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20208,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",731,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",536,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3475,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1812,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2115,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1951,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",457,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",427,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",202,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2197,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"OVC","OVC5_0","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",97,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",183,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",66,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1175,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",962,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5180,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1036,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1404,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2449,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1126,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",323,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",131,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",724,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8851,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1241,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12690,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",26,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4103,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",42,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",210,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",603,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26831,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",110,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1663,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2862,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",22,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_5","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",177,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",68,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_1","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5509,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",132,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",22,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_2","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",286,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6215,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",36,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","HIS",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",955,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",84,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"DIA","DIA1_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","AIAN",-71.5003609199997,43.6559501130005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5747,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",111,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",19617,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",741,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",47,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",739,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",193,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1716,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",44,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2943,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2356,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",426,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NE","Nebraska","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CKD","CKD1_0","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3982,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",285,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1382,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_3","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",327,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_2","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",159,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_2","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_2","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",537,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",18790,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"OVC","OVC5_0","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",332,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_1","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",189,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","RACE","API",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",675,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.50036091999965 43.65595011300047)",33,"COPD","COPD1_2","NMBR","RACE","API",-71.5003609199997,43.6559501130005
2018,2018,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",80,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3826,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_5","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"NE","Nebraska","NVSS","Asthma","Asthma mortality rate","Number",23,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"AST","AST4_1","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1669,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",116,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"ALC","ALC6_0","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",241,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",624,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CKD","CKD1_0","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",316,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_5","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","RACE","API",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"ALC","ALC6_0","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2420,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",447,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_1","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"DIA","DIA1_2","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","RACE","BLK",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12978,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_1","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_1","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",82,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_2","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CKD","CKD1_0","NMBR","RACE","BLK",-71.5003609199997,43.6559501130005
2018,2018,"ND","North Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"AST","AST4_1","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_3","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",169,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"COPD","COPD1_1","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3540,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_2","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"ND","North Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",388,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"OVC","OVC5_0","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"ALC","ALC6_0","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",943,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_1","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",480,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_3","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NH","New Hampshire","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"AST","AST4_1","NMBR","RACE","HIS",-71.5003609199997,43.6559501130005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1224,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_2","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"NJ","New Jersey","NVSS","Alcohol","Chronic liver disease mortality","Number",83,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"ALC","ALC6_0","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",145,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_5","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"ND","North Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",664,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"DIA","DIA1_1","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_2","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1347,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"COPD","COPD1_2","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2018,2018,"NJ","New Jersey","NVSS","Asthma","Asthma mortality rate","Number",38,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"AST","AST4_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8055,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_3","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6020,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"DIA","DIA1_1","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1672,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"OVC","OVC5_0","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",127,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"NE","Nebraska","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2335,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"COPD","COPD1_2","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"NC","North Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",8274,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CKD","CKD1_0","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",18716,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5918,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",187,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3537,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1630,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",1091,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",617,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",107,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",565,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",105,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1138,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",673,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3089,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1775,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2215,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1428,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1336,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",56,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",531,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",143,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",507,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",13288,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",20563,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",304,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",516,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",21388,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",364,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3246,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5453,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",79,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4420,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",544,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",451,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2076,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8715,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3942,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",557,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",145,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2015,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1549,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",664,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1709,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1402,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",470,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1073,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1362,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1412,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1639,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",866,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",316,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",35,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",66,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15830,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1480,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",327,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",146,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",300,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",94,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",875,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",917,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",170,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3129,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4637,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",161,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1770,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5589,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",152,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",27428,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",131,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",77,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",47,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1592,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2631,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",41,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",242,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5310,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",196,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8522,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",73,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",579,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",147,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3669,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",42,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",456,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",657,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1050,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2900,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6864,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",53,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",127,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",27,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",514,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2801,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9602,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5470,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2558,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",275,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",289,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7757,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",845,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2901,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3694,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",132,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",788,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",99,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",70,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",331,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1291,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",23942,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5178,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",324,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2926,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",363,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",71,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",29,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1535,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",974,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3752,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4436,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",267,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",8381,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7803,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2788,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",611,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2872,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5101,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6847,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",273,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",43806,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",84,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",101,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",167,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",632,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1439,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",575,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",23,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",27155,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6192,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",62,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6981,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",811,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1038,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12749,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",675,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",100,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4245,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",694,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1155,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",158,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1836,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",311,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2925,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7845,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",318,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1312,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",314,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4129,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",61,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",261,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3571,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14713,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",74,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6484,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10780,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",1670,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",26,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",20,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",594,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",85,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",114,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1975,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2958,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5125,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6787,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",311,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",40,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2277,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",1088,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6441,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4830,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1665,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1437,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",168,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",162,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1574,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1791,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",772,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",29871,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",43,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",96,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",55,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5067,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12039,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",647,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",639,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3180,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",492,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",40,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",314,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1103,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",36,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",785,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",237,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3117,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_2","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",886,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",9889,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",709,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",6034,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",287,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",924,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",76,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6758,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",30730,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1494,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2818,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9114,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3280,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2296,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",36,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4008,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",635,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",125,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",220,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",230,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",38,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",150,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",289,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",135,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1284,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_5","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",37966,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2409,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4904,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1110,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4248,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",67,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3222,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2533,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",708,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3550,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_5","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",116,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CKD","CKD1_0","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2655,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2448,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",66,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",496,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_2","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1153,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_2","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",918,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_3","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2414,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",783,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",718,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",256,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",48,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_2","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3648,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",370,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",22418,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11903,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1524,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2018,2018,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",84,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14041,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2077,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_2","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",529,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",67,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_1","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2512,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_1","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",54583,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"ALC","ALC6_0","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",176,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9521,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CKD","CKD1_0","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",22,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",117,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","AIAN",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"AST","AST4_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1235,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"COPD","COPD1_1","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"AST","AST4_1","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6725,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1704,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"OVC","OVC5_0","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",44,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",202,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3136,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",414,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_2","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"COPD","COPD1_2","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_5","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Alcohol","Chronic liver disease mortality","Number",84,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"ALC","ALC6_0","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",44,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1109,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"DIA","DIA1_1","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5760,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_1","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",18403,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_1","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",647,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_3","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",14544,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_1","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NJ","New Jersey","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",500,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CKD","CKD1_0","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NJ","New Jersey","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7977,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"OVC","OVC5_0","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2553,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_2","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"NM","New Mexico","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CKD","CKD1_0","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1328,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_3","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2358,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_3","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"NY","New York","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"DIA","DIA1_2","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Alcohol","Chronic liver disease mortality","Number",190,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"ALC","ALC6_0","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",53,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_2","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",244,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_2","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"NV","Nevada","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2030,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"OVC","OVC5_0","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NV","Nevada","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",868,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"DIA","DIA1_1","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"NM","New Mexico","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",250,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"COPD","COPD1_1","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2019,2019,"NY","New York","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"AST","AST4_1","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"NJ","New Jersey","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"DIA","DIA1_2","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",366,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"COPD","COPD1_1","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4314,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_5","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",34,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",23325,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",41,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",132,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",148,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7033,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",311,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3886,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",274,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6627,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",63,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",296,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",69,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",65,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",189,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",275,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",924,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1492,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",1012,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15551,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6152,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26489,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",65,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1803,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1536,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2934,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",658,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6420,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4737,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7188,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4825,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",16748,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",494,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6693,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",41,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",163,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",1400,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1037,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38263,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","API",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",135,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",752,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",38,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",84,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10310,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",36,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",67,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2134,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5575,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5002,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1555,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",581,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3404,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3926,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7189,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",36101,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3352,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",254,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",75,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",50,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",101,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",88,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",797,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5696,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",131,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",327,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",61,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",11133,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",1479,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3254,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",53,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",13629,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3202,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3731,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2701,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1799,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20579,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",363,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1223,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5407,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",38,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",611,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",13015,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",1308,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",112,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",194,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",79,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",155,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",273,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",414,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",37,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",33145,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",36,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",10370,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2899,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",100,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",94,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",159,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",148,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",41,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",86,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3005,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",120,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2960,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",8945,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",93,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3655,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25405,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",86,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",76,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",70,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11218,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",717,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",225,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",58,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",819,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",122,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5587,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",32,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4227,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1674,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10264,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4605,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",18819,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1181,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",71,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3171,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",89,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5651,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9251,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6197,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",169,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10960,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",91,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2051,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1450,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6184,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5841,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8992,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",79,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9585,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6477,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5437,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1593,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",755,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",15679,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",29160,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",52,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",12332,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",13632,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",41,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1409,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",77,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28259,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3726,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",71,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",42,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",302,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1089,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",19057,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",46,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",7437,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",487,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",55,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11280,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",21,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",94,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",1622,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",397,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",134,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2635,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15531,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2740,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",14809,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",83,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",12227,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",217,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4541,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",471,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",46,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",116,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",13502,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",911,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2333,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",966,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3383,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2619,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6688,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",45,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",275,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",95,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",225,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",50,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",220,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4357,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1055,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4975,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",95,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1168,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2491,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",14240,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4540,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4142,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",78,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5274,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",30,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",32,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6365,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",518,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",124,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",19444,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",14074,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",775,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1965,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",244,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2682,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2202,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6446,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3733,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",71,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",480,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",213,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",73,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3410,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",592,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",77,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",6980,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6148,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3391,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",99,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6504,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",63,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",344,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3074,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_3","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",525,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",135,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9137,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1525,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",16225,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_2","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",996,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",97,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",403,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5600,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_1","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3144,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",225,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",610,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",54,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",37,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_2","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1341,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",40,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",343,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"OVC","OVC5_0","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6469,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3335,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",917,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",80,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1541,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",269,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CKD","CKD1_0","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3253,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1048,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_5","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9586,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CKD","CKD1_0","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",70,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Alcohol","Chronic liver disease mortality","Number",898,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"ALC","ALC6_0","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20880,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",789,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_5","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5958,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_2","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",35,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",29,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15412,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_3","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7128,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_2","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5335,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Alcohol","Chronic liver disease mortality","Number",165,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"ALC","ALC6_0","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",159,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",66,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CKD","CKD1_0","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2334,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",73,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_3","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",32299,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_2","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",25,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"COPD","COPD1_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",173,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_1","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Asthma","Asthma mortality rate","Number",123,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"AST","AST4_1","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",137,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_1","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",150,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"DIA","DIA1_2","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2018,2018,"OK","Oklahoma","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"AST","AST4_1","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"OK","Oklahoma","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"DIA","DIA1_2","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OR","Oregon","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",56,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"COPD","COPD1_2","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"OK","Oklahoma","NVSS","Alcohol","Chronic liver disease mortality","Number",46,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"ALC","ALC6_0","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_2","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"OR","Oregon","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"AST","AST4_1","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"NY","New York","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",94,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"OVC","OVC5_0","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2019,2019,"OR","Oregon","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2479,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"OVC","OVC5_0","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"PA","Pennsylvania","NVSS","Asthma","Asthma mortality rate","Number",27,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"AST","AST4_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"OK","Oklahoma","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8607,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"OVC","OVC5_0","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",16949,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"OR","Oregon","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2055,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"DIA","DIA1_1","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"ALC","ALC6_0","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1933,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_5","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4588,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CKD","CKD1_0","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",9760,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_3","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",45,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"OK","Oklahoma","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7059,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"COPD","COPD1_2","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"OH","Ohio","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",7052,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"COPD","COPD1_2","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",118,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",392,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2264,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1858,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2681,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",346,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2253,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",659,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10312,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",110,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",78,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2703,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",90,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1231,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",53,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",276,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",810,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",154,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",467,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1450,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",100,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",884,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",22484,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",607,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",826,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1474,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1129,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5889,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",141,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",50,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",84,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",619,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",33,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",86,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",77,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3168,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",811,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",98,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",811,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",26,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",66,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",28,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",375,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1031,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",240,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",372,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1520,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",40,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3977,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",497,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",431,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4933,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",485,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10579,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",95,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3538,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",126,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",240,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",93,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",407,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",850,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2571,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5243,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",208,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",28,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1676,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",65,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3133,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7752,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",72,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",769,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",27,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8799,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",1118,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3842,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",26,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1131,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",69,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",70,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",992,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",676,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6190,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",608,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1187,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",125,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",124,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1840,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",742,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",42,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1186,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1523,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6658,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14402,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",862,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1345,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",510,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",108,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6408,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",23,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",427,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1150,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",941,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",55,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",34,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",397,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",215,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",156,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",792,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3518,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2404,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2473,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7661,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",46,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",94,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2819,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1373,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6843,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5683,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",40,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",11433,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",45,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",141,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2362,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13685,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1915,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",9789,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2980,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",372,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",82,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1271,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",239,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",71,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",17818,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",153,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4888,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",51,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1706,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",464,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1109,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",192,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",127,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",528,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1553,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",31,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",141,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2237,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",420,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",511,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",858,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",81,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1364,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4690,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5048,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1030,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6741,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1173,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",726,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2800,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",99,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",40,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_3","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",288,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",773,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4935,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"ALC","ALC6_0","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",218,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_5","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1721,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10629,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"OVC","OVC5_0","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_1","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2816,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"ALC","ALC6_0","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"PA","Pennsylvania","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",814,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"OVC","OVC5_0","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1042,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",53,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2665,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_2","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",484,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2682,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1103,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",270,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_1","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",68,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_2","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",993,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3136,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",521,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_2","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_3","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",699,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_5","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","RACE","AIAN",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"DIA","DIA1_2","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","RACE","BLK",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",33,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CKD","CKD1_0","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"OVC","OVC5_0","NMBR","RACE","HIS",-100.373530637,44.3531300530005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",44,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"SD","South Dakota","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-100.3735306369997 44.353130053000484)",46,"CKD","CKD1_0","NMBR","RACE","API",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_2","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2018,2018,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"AST","AST4_1","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"SD","South Dakota","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1105,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"COPD","COPD1_2","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CKD","CKD1_0","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",70,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_2","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",723,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_3","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"SD","South Dakota","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",461,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"DIA","DIA1_1","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1212,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_5","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"SC","South Carolina","NVSS","Alcohol","Chronic liver disease mortality","Number",298,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"ALC","ALC6_0","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",567,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3043,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_1","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Alcohol","Chronic liver disease mortality","Number",98,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"ALC","ALC6_0","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_1","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5780,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_2","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",176,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_2","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"SC","South Carolina","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",330,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"COPD","COPD1_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"COPD","COPD1_2","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Asthma","Asthma mortality rate","Number",43,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"AST","AST4_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3859,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_1","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"SC","South Carolina","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"AST","AST4_1","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_5","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1599,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2018,2018,"SD","South Dakota","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"AST","AST4_1","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2019,2019,"SC","South Carolina","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.04537120699968 33.998821303000454)",45,"DIA","DIA1_1","NMBR","RACE","AIAN",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-71.52247031399963 41.70828019300046)",44,"OVC","OVC5_0","NMBR","RACE","AIAN",-71.5224703139996,41.7082801930005
2019,2019,"PA","Pennsylvania","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1221,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"DIA","DIA1_1","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2384,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",24,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",9527,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1046,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",20,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",6635,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2651,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",166,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",28,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3882,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3257,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",95,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",9000,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",72,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1899,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6053,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",593,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",133,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9025,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",8651,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",48,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",29,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",22088,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",270,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",260,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3004,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",39,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",11641,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",5863,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",85,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7499,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",28271,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",39226,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",10456,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",67,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",10770,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",816,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2552,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",5526,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",1037,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",15543,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",694,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",12433,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",103,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",2816,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",15750,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4710,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1499,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",16418,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",414,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",46139,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",10607,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",127,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",764,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1413,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",441,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4439,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1987,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",107,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4804,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",912,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",96,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",338,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",2280,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",9970,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",522,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3295,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2491,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1839,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1536,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",54,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",213,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2059,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",2620,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1587,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",34,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",1711,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",12262,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1208,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",51,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",41,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",33,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",14238,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",61192,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1074,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",23614,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",12386,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",16814,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",953,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",214,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",10807,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",23,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",261,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",399,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",42716,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",845,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",87,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",115,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",63,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",104,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",684,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",819,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3435,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",184,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",39,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",8639,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",207,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3929,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",92,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10085,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",10515,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",46,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",57,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",4091,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",25,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1495,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",24,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1707,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",84,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",11318,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5429,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",409,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",62,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",197,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1221,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5474,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",205,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",109,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3604,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",813,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",11038,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",42,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6054,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4443,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",20,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",80,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",32,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",40,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",816,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1500,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2357,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",29,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",293,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",72,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7386,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",895,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2045,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",51,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",764,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",29,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",48,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",10679,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2238,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",27,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6041,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",16553,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",21726,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",114,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",212,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",9386,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",45,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1800,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",25852,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",170,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1205,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","AIAN",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1630,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4117,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",815,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",613,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",4359,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",79,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",44,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",119,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",313,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8311,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",60,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",30078,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",151,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",82,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1837,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_2","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",18168,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",892,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",92,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4989,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",19607,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",32921,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",82,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",64,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",798,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",25589,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",500,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6223,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"OVC","OVC5_0","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",676,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",4944,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",23103,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",4143,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_1","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",215,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2364,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1491,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_5","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2922,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",51,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2652,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",81,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_2","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","RACE","API",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",68,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3100,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",13158,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",105,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2784,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_5","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"VA","Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",157,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"ALC","ALC6_0","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2883,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2664,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2019,2019,"TX","Texas","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",26298,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"OVC","OVC5_0","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",1543,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",59,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",4596,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",9400,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Alcohol","Chronic liver disease mortality","Number",91,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"ALC","ALC6_0","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",118,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",950,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CKD","CKD1_0","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",7161,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",20287,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_2","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",34,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1838,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"DIA","DIA1_2","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",63,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"UT","Utah","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"AST","AST4_1","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_2","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",8626,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_3","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"TN","Tennessee","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"DIA","DIA1_2","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",5111,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",17614,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"COPD","COPD1_2","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1261,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"OVC","OVC5_0","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",32,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",39,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CKD","CKD1_0","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TN","Tennessee","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"COPD","COPD1_2","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",275,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_2","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"TX","Texas","NVSS","Alcohol","Chronic liver disease mortality","Number",297,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"ALC","ALC6_0","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",42,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3000,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_1","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3077,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CKD","CKD1_0","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",147,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_1","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",907,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"UT","Utah","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"COPD","COPD1_1","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",584,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_3","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2018,2018,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",10046,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_3","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3961,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"TX","Texas","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3441,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"DIA","DIA1_1","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",503,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_5","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"TX","Texas","NVSS","Asthma","Asthma mortality rate","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"AST","AST4_1","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"VA","Virginia","NVSS","Asthma","Asthma mortality rate","Number",38,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"AST","AST4_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",159,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",853,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",52,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1512,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",622,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",78,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",143,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",45,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2604,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",117,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1635,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",156,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1470,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5256,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",63,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",10405,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",854,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6763,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",9985,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",345,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",826,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",114,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",5692,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",867,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",159,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",255,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6004,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2534,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",102,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",523,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",89,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",3067,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",646,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",69,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",81,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8871,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3542,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",109,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",313,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14210,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2607,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2265,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",51,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6474,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",86,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",55,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3071,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",543,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3051,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3619,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",51,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",197,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",443,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7946,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",183,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",172,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1321,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",309,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1426,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4497,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1368,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",30,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1349,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",4351,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",55,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5245,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15962,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",392,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",276,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",221,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3379,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",566,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",60,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2763,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1397,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",679,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",20434,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3047,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",393,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",85,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",376,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",8054,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1808,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",37,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",393,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5713,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",127,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",20,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",112,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2565,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",593,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",123,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",2535,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",326,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2193,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",3923,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",573,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2938,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6082,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",33,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3532,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",32,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2524,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4127,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",16348,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",63,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",48,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",504,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7656,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",249,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",285,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",183,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",433,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",750,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3376,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",301,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",269,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2711,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2624,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5253,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6669,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",21,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",488,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",328,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",394,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1711,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4138,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",378,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",867,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",49,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",356,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",23,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3298,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",468,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11862,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",871,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11326,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1044,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5127,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8869,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4463,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",104,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",36,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2753,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",3739,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",370,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",239,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",77,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1776,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",167,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5467,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",607,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6123,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3828,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1465,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",331,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1444,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",53,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5944,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",7722,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",8337,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",625,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",816,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",739,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",10451,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",89,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2746,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",125,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",5389,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",92,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",217,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",338,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",30,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",103,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",101,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1343,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",4228,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1620,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",79,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",90,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",35,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8306,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1001,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",52,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",7008,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5572,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",429,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",54,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",80,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",4912,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",28,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",2854,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",139,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",190,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1443,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",56,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",68,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",5025,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",5671,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",71,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",38,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3176,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",21,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",14623,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",91,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",999,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",80,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",79,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",364,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2565,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",13199,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",3032,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",271,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",819,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",92,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",131,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",95,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",6330,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",336,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",3480,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",888,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",138,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",360,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",232,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4106,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",329,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Alcohol","Chronic liver disease mortality","Number",55,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"ALC","ALC6_0","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",61,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",87,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",319,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",218,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",941,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",2488,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",8626,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",117,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_5","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",15115,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1922,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",295,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",41,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_2","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",6672,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_3","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",733,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_2","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",263,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_5","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",209,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_3","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",73,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",10449,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_1","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","AIAN",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",41,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_2","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",38,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_5","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",152,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_1","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",5483,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_2","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WI","Wisconsin","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2418,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CKD","CKD1_0","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",12241,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",891,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Alcohol","Chronic liver disease mortality","Number",1089,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"ALC","ALC6_0","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Alcohol","Chronic liver disease mortality","Number",139,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"ALC","ALC6_0","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3228,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",15062,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_2","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",33,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",153,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",2607,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_1","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",135,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_5","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",24,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",223,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_1","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",36,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2902,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CKD","CKD1_0","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",82,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"WA","Washington","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",438,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"DIA","DIA1_1","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WA","Washington","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",2308,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CKD","CKD1_0","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"VT","Vermont","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",971,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"OVC","OVC5_0","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",145,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",56,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"COPD","COPD1_2","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",50,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",67,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"DIA","DIA1_1","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"ALC","ALC6_0","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"COPD","COPD1_2","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",6299,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",110,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_1","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CKD","CKD1_0","NMBR","RACE","BLK",-72.5176407909996,43.6253812390005
2019,2019,"WA","Washington","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",615,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"OVC","OVC5_0","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"VA","Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",3037,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"COPD","COPD1_1","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"VT","Vermont","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"AST","AST4_1","NMBR","RACE","HIS",-72.5176407909996,43.6253812390005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_3","NMBR","RACE","API",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"AST","AST4_1","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",6617,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_2","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"WV","West Virginia","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"AST","AST4_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_2","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"WI","Wisconsin","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",7353,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"OVC","OVC5_0","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VT","Vermont","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",437,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"DIA","DIA1_1","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",7534,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_3","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WA","Washington","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",6427,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"COPD","COPD1_2","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"WA","Washington","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"AST","AST4_1","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",11252,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_2","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"VA","Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"DIA","DIA1_2","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"VA","Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",362,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"OVC","OVC5_0","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",104,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8856,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2914,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4236,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",112,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",36,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2937,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7189,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7909,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9303,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",360,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",934,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7572,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1294,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",867,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5800,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",182,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1049,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2260,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4738,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9699,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",511,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",100,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9390,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",888,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","API",-157.857749403,21.3048504350004
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",17483,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4865,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",716,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",18815,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8254,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",224,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1071,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",57,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",230,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2665,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",434,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4107,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3998,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",48,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",53,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6242,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",372,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1497,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1466,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3560,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1811,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1123,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",26,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1273,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",792,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2264,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3792,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2431,"","","Gender","Male","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","GENDER","GENM",-76.6092601109996,39.2905809640005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4077,"","","Gender","Female","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","GENDER","GENF",-94.7942005029997,46.3556487360005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5144,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5045,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",636,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",970,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1318,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",27,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",82,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","AIAN",-147.722059036,64.8450799570005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",117,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1329,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",159,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2850,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1072,"","","Gender","Female","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","GENDER","GENF",-68.9850313359996,45.2542288940005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",324,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","AIAN",-72.0826906749996,42.2768704700005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7421,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3250,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",20,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",65,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",50,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7023,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1081,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",155,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",110,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8378,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",113,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1460,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",816,"","","Gender","Female","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","GENDER","GENF",-71.5224703139996,41.7082801930005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2741,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",205,"","","Race/Ethnicity","Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","HIS",-72.6498409519996,41.5626610200005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1395,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2524,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2098,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",739,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",216,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5490,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6881,"","","Gender","Female","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","GENDER","GENF",-84.7143902699997,44.6613195430005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",97,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1146,"","","Gender","Male","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","GENDER","GENM",-117.071840564,39.4932403900005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",74,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","BLK",-93.8164905559997,42.4694009130005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1762,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",407,"","","Gender","Female","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","GENDER","GENF",-72.5176407909996,43.6253812390005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3261,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",25,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1709,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3378,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",53,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",16570,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","WHT",-81.9289605389997,28.9320403770005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",110,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9286,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2892,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","API",-89.5380308249997,32.7455100990005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",368,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","API",-120.47001079,47.5222786290005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",462,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3820,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",182,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",101,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6282,"","","Overall","Overall","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","OVERALL","OVR",-86.6318607619997,32.8405711220005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",186,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",37074,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","RACE","API",-75.5777411679996,39.0088306670005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",2862,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4385,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",1035,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1316,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6670,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",726,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5970,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",85,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","API",-111.763811277,34.8659702800005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8905,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3550,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8915,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",11539,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",1141,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1075,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",88,"","","Race/Ethnicity","Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","HIS",-89.8163707419997,44.3931911740005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",388,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",124,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","API",-117.071840564,39.4932403900005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1570,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2014,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","API",-92.2744907429997,34.7486501240004
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",121,"","","Race/Ethnicity","Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","HIS",-79.1592504629996,35.4662209750005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",27333,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5921,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",89,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3215,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5204,"","","Gender","Female","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","GENDER","GENF",-83.6275803459997,32.8396810930005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1461,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",2368,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5741,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",111,"","","Race/Ethnicity","Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","HIS",-82.4042600559997,40.0602101410005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1174,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",436,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1667,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",119,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",363,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","HIS",-86.6318607619997,32.8405711220005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",85,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2579,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2786,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",117,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",360,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",203,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",14172,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2105,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",776,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2468,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",218,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","AIAN",-120.999999538,37.6386401230005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",182,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",58,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","HIS",-92.5663000529997,38.6357907760005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4563,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7387,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8032,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",72,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","API",-111.763811277,34.8659702800005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",69,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","API",-106.133610921,38.8438407570005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","RACE","HIS",-109.424420645,47.0665289720005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",362,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3746,"","","Overall","Overall","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","OVERALL","OVR",-98.2007812269996,38.3477403000005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",354,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13679,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",18334,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",145,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4419,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7865,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",126,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",607,"","","Gender","Female","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","GENDER","GENF",-100.373530637,44.3531300530005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8448,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",333,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",26,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",20,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","BLK",-111.587130635,39.3607001710005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",76,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","API",-106.133610921,38.8438407570005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",783,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",339,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",28,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",35,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",174,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1199,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",40,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","AIAN",-89.8163707419997,44.3931911740005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2371,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",116,"","","Race/Ethnicity","Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","HIS",-86.1499601939997,39.7669104520004
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1079,"","","Gender","Female","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","GENDER","GENF",-106.240580985,34.5208809520005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",833,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1682,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","BLK",-92.4456800709997,31.3126606440005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3349,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7530,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4410,"","","Gender","Female","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","GENDER","GENF",-85.7744909139997,35.6809405800005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1273,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3752,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",137,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",10348,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","BLK",-157.857749403,21.3048504350004
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4176,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3429,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7540,"","","Gender","Female","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","GENDER","GENF",-88.9977101779997,40.4850102830005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",53,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2224,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","BLK",-81.9289605389997,28.9320403770005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",14315,"","","Overall","Overall","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","OVERALL","OVR",-88.9977101779997,40.4850102830005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",679,"","","Gender","Female","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","GENDER","GENF",-109.424420645,47.0665289720005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",345,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1067,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3953,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","WHT",-92.2744907429997,34.7486501240004
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1928,"","","Gender","Male","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","GENDER","GENM",-98.2007812269996,38.3477403000005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",141,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",571,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13207,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",248,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3157,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",36091,"","","Overall","Overall","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","OVERALL","OVR",-120.999999538,37.6386401230005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",682,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",282,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",970,"","","Overall","Overall","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","OVERALL","OVR",-100.118421049,47.4753197790005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3541,"","","Gender","Male","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","GENDER","GENM",-94.7942005029997,46.3556487360005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2806,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","WHT",-111.587130635,39.3607001710005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","API",-93.8164905559997,42.4694009130005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5866,"","","Overall","Overall","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","OVERALL","OVR",-97.5210702139997,35.4720313560005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",49,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",72,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2131,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",400,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8869,"","","Overall","Overall","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","OVERALL","OVR",-74.2736912879997,40.1305700480005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3190,"","","Gender","Male","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","GENDER","GENM",-111.763811277,34.8659702800005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",571,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2662,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","BLK",-79.1592504629996,35.4662209750005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",18670,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","WHT",-99.4267702059997,31.8272404070005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",12010,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","API",-147.722059036,64.8450799570005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","HIS",-84.7749710479997,37.6459702710005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",221,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2083,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",40,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",564,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",400,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","API",-99.3657206229997,41.6410409880005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4632,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2421,"","","Gender","Female","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","GENDER","GENF",-89.5380308249997,32.7455100990005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2876,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",852,"","","Gender","Male","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","GENDER","GENM",-71.5003609199997,43.6559501130005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",41,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",48,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7519,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","WHT",-89.8163707419997,44.3931911740005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1495,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",18413,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",356,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8029,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","AIAN",-82.4042600559997,40.0602101410005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",79,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",10626,"","","Overall","Overall","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","OVERALL","OVR",-83.6275803459997,32.8396810930005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",997,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2385,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3231,"","","Gender","Male","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","GENDER","GENM",-84.7749710479997,37.6459702710005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7233,"","","Race/Ethnicity","White, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","WHT",-74.2736912879997,40.1305700480005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",72,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",404,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",56,"","","Race/Ethnicity","Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","HIS",-81.0453712069997,33.9988213030005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13575,"","","Gender","Male","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","GENDER","GENM",-99.4267702059997,31.8272404070005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",689,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",403,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",257,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","BLK",-72.6498409519996,41.5626610200005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",272,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","GENDER","GENF",-77.036871,38.907192
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",959,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6254,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9240,"","","Gender","Female","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","GENDER","GENF",-75.5439704269996,42.8270010320005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",70,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2375,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8111,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7378,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2983,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5121,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1424,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",773,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",377,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1759,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2244,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",85,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",213,"","","Gender","Female","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","GENDER","GENF",-147.722059036,64.8450799570005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",236,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",33,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",24,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",184,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1226,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2486,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1310,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2842,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","BLK",-120.999999538,37.6386401230005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",136,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",204,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",866,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",11400,"","","Gender","Male","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","GENDER","GENM",-81.9289605389997,28.9320403770005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",12178,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8247,"","","Gender","Female","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","GENDER","GENF",-82.4042600559997,40.0602101410005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","AIAN",-98.2007812269996,38.3477403000005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","API",-106.240580985,34.5208809520005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","HIS",-147.722059036,64.8450799570005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",27,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1088,"","","Gender","Female","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","GENDER","GENF",-114.363730042,43.6826300050005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1889,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1547,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4858,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","AIAN",-86.6318607619997,32.8405711220005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5340,"","","Race/Ethnicity","White, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","WHT",-81.0453712069997,33.9988213030005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3811,"","","Gender","Male","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","GENDER","GENM",-89.8163707419997,44.3931911740005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",17757,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",117,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",80,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","BLK",-99.3657206229997,41.6410409880005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",113,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4088,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","WHT",-92.4456800709997,31.3126606440005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4885,"","","Race/Ethnicity","White, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","WHT",-111.763811277,34.8659702800005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2254,"","","Gender","Male","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","GENDER","GENM",-93.8164905559997,42.4694009130005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2234,"","","Race/Ethnicity","White, non-Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","WHT",-114.363730042,43.6826300050005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",78,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1035,"","","Gender","Male","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","GENDER","GENM",-106.240580985,34.5208809520005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1510,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","BLK",-76.6092601109996,39.2905809640005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4577,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4675,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",619,"","","Gender","Male","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","GENDER","GENM",-100.373530637,44.3531300530005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","RACE","HIS",-75.5777411679996,39.0088306670005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",5087,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",26,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",27337,"","","Overall","Overall","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","OVERALL","OVR",-99.4267702059997,31.8272404070005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",11469,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","WHT",-84.7143902699997,44.6613195430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",192,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3595,"","","Gender","Female","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","GENDER","GENF",-84.7749710479997,37.6459702710005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",542,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1336,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",504,"","","Gender","Female","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","GENDER","GENF",-75.5777411679996,39.0088306670005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",164,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4195,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","API",-92.5663000529997,38.6357907760005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7338,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1608,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",37,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1367,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",70,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",457,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3710,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6845,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",14102,"","","Race/Ethnicity","White, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","WHT",-82.4042600559997,40.0602101410005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",21,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","AIAN",-114.363730042,43.6826300050005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","RACE","HIS",-77.036871,38.907192
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1964,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",292,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",67,"","","Race/Ethnicity","Hispanic","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","HIS",-92.4456800709997,31.3126606440005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5082,"","","Race/Ethnicity","White, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","WHT",-97.5210702139997,35.4720313560005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",766,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",15817,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",255,"","","Race/Ethnicity","Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","HIS",-77.8607002939996,40.7937301520005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",203,"","","Race/Ethnicity","Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","HIS",-72.0826906749996,42.2768704700005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",107,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","API",-72.0826906749996,42.2768704700005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",768,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","RACE","WHT",-72.5176407909996,43.6253812390005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1020,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","RACE","WHT",-100.118421049,47.4753197790005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5170,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5080,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3322,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","API",-120.999999538,37.6386401230005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6306,"","","Overall","Overall","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","OVERALL","OVR",-120.155031326,44.5674494240005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",59,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","API",-84.7143902699997,44.6613195430005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",42,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4389,"","","Overall","Overall","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","OVERALL","OVR",-72.6498409519996,41.5626610200005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1871,"","","Overall","Overall","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","OVERALL","OVR",-71.5003609199997,43.6559501130005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",248,"","","Gender","Female","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","GENDER","GENF",-77.036871,38.907192
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2117,"","","Overall","Overall","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","OVERALL","OVR",-117.071840564,39.4932403900005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",141,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2316,"","","Gender","Male","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","GENDER","GENM",-92.2744907429997,34.7486501240004
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6045,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",699,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",1838,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",1804,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7383,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",361,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","AIAN",-97.5210702139997,35.4720313560005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2033,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3906,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1876,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","BLK",-75.5439704269996,42.8270010320005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3137,"","","Gender","Female","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","GENDER","GENF",-86.6318607619997,32.8405711220005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8901,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1378,"","","Gender","Female","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","GENDER","GENF",-111.587130635,39.3607001710005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",190,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",682,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6615,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1946,"","","Gender","Female","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","GENDER","GENF",-98.2007812269996,38.3477403000005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",157,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","RACE","BLK",-75.5777411679996,39.0088306670005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1658,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","BLK",-78.4578904629997,37.5426806740005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1253,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",961,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2796,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",222,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13762,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",10850,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",51,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","AIAN",-84.7143902699997,44.6613195430005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1276,"","","Overall","Overall","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","OVERALL","OVR",-157.857749403,21.3048504350004
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",511,"","","Race/Ethnicity","Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","HIS",-106.133610921,38.8438407570005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",198,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2019,2019,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1792,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",21,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9804,"","","Overall","Overall","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","OVERALL","OVR",-86.1499601939997,39.7669104520004
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",4783,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",29,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",24362,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",124,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1508,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4457,"","","Gender","Male","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","GENDER","GENM",-78.4578904629997,37.5426806740005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5881,"","","Race/Ethnicity","Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","HIS",-120.999999538,37.6386401230005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4118,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1405,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","WHT",-71.5224703139996,41.7082801930005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3174,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8095,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",100,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","API",-77.8607002939996,40.7937301520005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9940,"","","Race/Ethnicity","White, non-Hispanic","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","WHT",-79.1592504629996,35.4662209750005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",32,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","API",-86.1499601939997,39.7669104520004
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13223,"","","Overall","Overall","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","OVERALL","OVR",-84.7143902699997,44.6613195430005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2562,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6876,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3305,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9832,"","","Gender","Female","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","GENDER","GENF",-77.8607002939996,40.7937301520005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",532,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3149,"","","Gender","Female","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","GENDER","GENF",-120.155031326,44.5674494240005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1454,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",72,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",32,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","AIAN",-99.4267702059997,31.8272404070005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2431,"","","Gender","Female","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","GENDER","GENF",-93.8164905559997,42.4694009130005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",305,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1955,"","","Gender","Male","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","GENDER","GENM",-72.6498409519996,41.5626610200005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",409,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","API",-75.5439704269996,42.8270010320005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8262,"","","Gender","Male","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","GENDER","GENM",-75.5439704269996,42.8270010320005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",536,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",25,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","AIAN",-106.133610921,38.8438407570005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",845,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",18688,"","","Overall","Overall","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","OVERALL","OVR",-77.8607002939996,40.7937301520005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4685,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4238,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",188,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3517,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4264,"","","Gender","Male","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","GENDER","GENM",-120.47001079,47.5222786290005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4209,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",134,"","","Race/Ethnicity","Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","HIS",-83.6275803459997,32.8396810930005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",60,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",245,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","BLK",-120.47001079,47.5222786290005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",323,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","BLK",-97.5210702139997,35.4720313560005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2941,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","API",-106.240580985,34.5208809520005
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","RACE","BLK",-68.9850313359996,45.2542288940005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1009,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",158,"","","Race/Ethnicity","Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","HIS",-117.071840564,39.4932403900005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",926,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",96,"","","Race/Ethnicity","Hispanic","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","HIS",-111.587130635,39.3607001710005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6313,"","","Race/Ethnicity","White, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","WHT",-84.7749710479997,37.6459702710005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",183,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7007,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","API",-108.109830353,43.2355413430005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2796,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",418,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1459,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",389,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","API",-99.4267702059997,31.8272404070005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2625,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7138,"","","Overall","Overall","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","OVERALL","OVR",-81.0453712069997,33.9988213030005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1845,"","","Race/Ethnicity","White, non-Hispanic","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","RACE","WHT",-71.5003609199997,43.6559501130005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",171,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",285,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",175,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",674,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","BLK",-86.1499601939997,39.7669104520004
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",11678,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",388,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",73,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4167,"","","Gender","Female","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","GENDER","GENF",-92.5663000529997,38.6357907760005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",394,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","RACE","BLK",-77.036871,38.907192
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",44,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","BLK",-71.5224703139996,41.7082801930005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8528,"","","Overall","Overall","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","OVERALL","OVR",-85.7744909139997,35.6809405800005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",17953,"","","Gender","Female","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","GENDER","GENF",-120.999999538,37.6386401230005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2894,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","AIAN",-111.587130635,39.3607001710005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1648,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3499,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",32,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4895,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1035,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","BLK",-85.7744909139997,35.6809405800005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1433,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","BLK",-89.5380308249997,32.7455100990005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2753,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","BLK",-83.6275803459997,32.8396810930005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",465,"","","Overall","Overall","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","OVERALL","OVR",-147.722059036,64.8450799570005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3467,"","","Gender","Male","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","GENDER","GENM",-120.155031326,44.5674494240005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",423,"","","Overall","Overall","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","OVERALL","OVR",-77.036871,38.907192
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",932,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","BLK",-74.2736912879997,40.1305700480005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13684,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5868,"","","Overall","Overall","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","OVERALL","OVR",-92.4456800709997,31.3126606440005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6455,"","","Race/Ethnicity","White, non-Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","WHT",-78.4578904629997,37.5426806740005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",190,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","API",-114.363730042,43.6826300050005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7571,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","WHT",-120.47001079,47.5222786290005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4816,"","","Overall","Overall","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","OVERALL","OVR",-93.8164905559997,42.4694009130005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8943,"","","Overall","Overall","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","OVERALL","OVR",-120.47001079,47.5222786290005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",455,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",616,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","BLK",-92.2744907429997,34.7486501240004
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5066,"","","Overall","Overall","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","OVERALL","OVR",-89.5380308249997,32.7455100990005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",64,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22860,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",35,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4366,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1298,"","","Race/Ethnicity","White, non-Hispanic","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","RACE","WHT",-100.373530637,44.3531300530005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",35,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5884,"","","Gender","Male","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","GENDER","GENM",-79.1592504629996,35.4662209750005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",15819,"","","Overall","Overall","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","OVERALL","OVR",-82.4042600559997,40.0602101410005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",39,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","BLK",-106.240580985,34.5208809520005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",221,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",505,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",189,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","BLK",-117.071840564,39.4932403900005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2181,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",570,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",16822,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",542,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",23862,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","WHT",-120.999999538,37.6386401230005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",11607,"","","Race/Ethnicity","White, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","WHT",-88.9977101779997,40.4850102830005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",591,"","","Gender","Female","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","GENDER","GENF",-157.857749403,21.3048504350004
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",986,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7987,"","","Overall","Overall","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","OVERALL","OVR",-89.8163707419997,44.3931911740005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1942,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7155,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",716,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3034,"","","Gender","Female","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","GENDER","GENF",-97.5210702139997,35.4720313560005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5430,"","","Overall","Overall","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","OVERALL","OVR",-106.133610921,38.8438407570005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",877,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1414,"","","Gender","Female","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","GENDER","GENF",-99.3657206229997,41.6410409880005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",1621,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2994,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",83,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","RACE","WHT",-77.036871,38.907192
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1661,"","","Race/Ethnicity","White, non-Hispanic","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","WHT",-117.071840564,39.4932403900005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",24,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",49,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",304,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4851,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3551,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1870,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","BLK",-88.9977101779997,40.4850102830005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4184,"","","Gender","Female","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","GENDER","GENF",-120.47001079,47.5222786290005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",117,"","","Race/Ethnicity","Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","HIS",-120.155031326,44.5674494240005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",10331,"","","Gender","Female","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","GENDER","GENF",-81.9289605389997,28.9320403770005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",30,"","","Race/Ethnicity","Hispanic","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","HIS",-92.2744907429997,34.7486501240004
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",196,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","API",-81.9289605389997,28.9320403770005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4619,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",17397,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",115,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","API",-76.6092601109996,39.2905809640005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",64,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",519,"","","Gender","Male","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","GENDER","GENM",-75.5777411679996,39.0088306670005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3593,"","","Race/Ethnicity","White, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","WHT",-98.2007812269996,38.3477403000005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",677,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",180,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","BLK",-94.7942005029997,46.3556487360005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4234,"","","Gender","Female","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","GENDER","GENF",-78.4578904629997,37.5426806740005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",26,"","","Race/Ethnicity","Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","HIS",-93.8164905559997,42.4694009130005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",611,"","","Race/Ethnicity","Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","HIS",-106.240580985,34.5208809520005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","BLK",-147.722059036,64.8450799570005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1093,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",43,"","","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8103,"","","Overall","Overall","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","OVERALL","OVR",-92.5663000529997,38.6357907760005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4482,"","","Gender","Male","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","GENDER","GENM",-85.7744909139997,35.6809405800005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7304,"","","Race/Ethnicity","White, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","WHT",-92.5663000529997,38.6357907760005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",668,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",49,"","","Race/Ethnicity","Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","HIS",-94.7942005029997,46.3556487360005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",159,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","API",-78.4578904629997,37.5426806740005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",82,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","API",-71.5224703139996,41.7082801930005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",37,"","","Race/Ethnicity","Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","HIS",-85.7744909139997,35.6809405800005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1299,"","","Race/Ethnicity","White, non-Hispanic","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","RACE","WHT",-109.424420645,47.0665289720005
2018,2018,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1023,"","","Overall","Overall","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","OVERALL","OVR",-75.5777411679996,39.0088306670005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1067,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8429,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7563,"","","Gender","Male","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","GENDER","GENM",-82.4042600559997,40.0602101410005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",17009,"","","Race/Ethnicity","White, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","WHT",-77.8607002939996,40.7937301520005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3038,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",96,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",98,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",293,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","BLK",-72.0826906749996,42.2768704700005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",711,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",631,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",208,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","API",-88.9977101779997,40.4850102830005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",97,"","","Race/Ethnicity","Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","HIS",-98.2007812269996,38.3477403000005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3670,"","","Race/Ethnicity","White, non-Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","WHT",-76.6092601109996,39.2905809640005
2018,2018,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4569,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",1741,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5136,"","","Gender","Male","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","GENDER","GENM",-83.6275803459997,32.8396810930005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5654,"","","Overall","Overall","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","OVERALL","OVR",-76.6092601109996,39.2905809640005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",201,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","BLK",-106.133610921,38.8438407570005
2019,2019,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4631,"","","Gender","Female","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","GENDER","GENF",-74.2736912879997,40.1305700480005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",28,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","API",-92.4456800709997,31.3126606440005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",112,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","API",-120.155031326,44.5674494240005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",70,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","RACE","AIAN",-109.424420645,47.0665289720005
2018,2018,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",96,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","BLK",-120.155031326,44.5674494240005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",632,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","BLK",-92.5663000529997,38.6357907760005
2018,2018,"NH","New Hampshire","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",964,"","","Gender","Female","POINT (-71.50036091999965 43.65595011300047)",33,"CVD","CVD1_4","NMBR","GENDER","GENF",-71.5003609199997,43.6559501130005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1668,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","BLK",-81.0453712069997,33.9988213030005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4926,"","","Gender","Female","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","GENDER","GENF",-86.1499601939997,39.7669104520004
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1158,"","","Race/Ethnicity","Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","HIS",-75.5439704269996,42.8270010320005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3863,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2778,"","","Gender","Female","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","GENDER","GENF",-106.133610921,38.8438407570005
2019,2019,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",222,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",346,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","API",-120.47001079,47.5222786290005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2281,"","","Gender","Female","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","GENDER","GENF",-72.6498409519996,41.5626610200005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",107,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","AIAN",-106.240580985,34.5208809520005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2859,"","","Gender","Male","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","GENDER","GENM",-92.4456800709997,31.3126606440005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1408,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",366,"","","Gender","Male","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","GENDER","GENM",-72.5176407909996,43.6253812390005
2019,2019,"DE","Delaware","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",872,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.57774116799965 39.008830667000495)",10,"CVD","CVD1_4","NMBR","RACE","WHT",-75.5777411679996,39.0088306670005
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",655,"","","Race/Ethnicity","Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","HIS",-111.763811277,34.8659702800005
2019,2019,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1265,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","RACE","BLK",-77.8607002939996,40.7937301520005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",313,"","","Race/Ethnicity","White, non-Hispanic","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","WHT",-147.722059036,64.8450799570005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","AIAN",-78.4578904629997,37.5426806740005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",125,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","AIAN",-79.1592504629996,35.4662209750005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1506,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",36,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",529,"","","Gender","Male","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","GENDER","GENM",-100.118421049,47.4753197790005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1251,"","","Gender","Male","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","GENDER","GENM",-99.3657206229997,41.6410409880005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","HIS",-89.5380308249997,32.7455100990005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4892,"","","Race/Ethnicity","Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","HIS",-99.4267702059997,31.8272404070005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",3277,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_2","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",38,"","","Race/Ethnicity","Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","HIS",-99.3657206229997,41.6410409880005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",23,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6688,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2019,2019,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",12930,"","","Overall","Overall","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","OVERALL","OVR",-79.1592504629996,35.4662209750005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2542,"","","Gender","Male","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","GENDER","GENM",-89.5380308249997,32.7455100990005
2018,2018,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",109,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","AIAN",-120.47001079,47.5222786290005
2019,2019,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6342,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",38,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_2","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8099,"","","Overall","Overall","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","OVERALL","OVR",-72.0826906749996,42.2768704700005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",705,"","","Gender","Male","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","GENDER","GENM",-71.5224703139996,41.7082801930005
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2690,"","","Race/Ethnicity","Hispanic","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","HIS",-81.9289605389997,28.9320403770005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",971,"","","Gender","Female","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","GENDER","GENF",-117.071840564,39.4932403900005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2043,"","","Race/Ethnicity","White, non-Hispanic","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","RACE","WHT",-68.9850313359996,45.2542288940005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4167,"","","Gender","Male","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","GENDER","GENM",-74.2736912879997,40.1305700480005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",193,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","BLK",-111.763811277,34.8659702800005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",121,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_5","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2804,"","","Gender","Male","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","GENDER","GENM",-106.133610921,38.8438407570005
2019,2019,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",738,"","","Gender","Male","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","GENDER","GENM",-109.424420645,47.0665289720005
2019,2019,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",64,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","API",-82.4042600559997,40.0602101410005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",218,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3814,"","","Gender","Male","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","GENDER","GENM",-72.0826906749996,42.2768704700005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","AIAN",-99.3657206229997,41.6410409880005
2019,2019,"VT","Vermont","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",779,"","","Overall","Overall","POINT (-72.51764079099962 43.62538123900049)",50,"CVD","CVD1_4","NMBR","OVERALL","OVR",-72.5176407909996,43.6253812390005
2018,2018,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",42,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","API",-89.8163707419997,44.3931911740005
2019,2019,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2303,"","","Gender","Female","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","GENDER","GENF",-92.2744907429997,34.7486501240004
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",27,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","RACE","API",-81.0453712069997,33.9988213030005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",1012,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_2","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",28,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","AIAN",-75.5439704269996,42.8270010320005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2019,2019,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",17502,"","","Overall","Overall","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","OVERALL","OVR",-75.5439704269996,42.8270010320005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6184,"","","Gender","Male","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","GENDER","GENM",-84.7143902699997,44.6613195430005
2018,2018,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3783,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","WHT",-72.6498409519996,41.5626610200005
2019,2019,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","API",-98.2007812269996,38.3477403000005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",33,"","","Race/Ethnicity","Hispanic","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","RACE","HIS",-71.5224703139996,41.7082801930005
2018,2018,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",24,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","API",-85.7744909139997,35.6809405800005
2019,2019,"WA","Washington","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",208,"","","Race/Ethnicity","Hispanic","POINT (-120.47001078999972 47.52227862900048)",53,"CVD","CVD1_4","NMBR","RACE","HIS",-120.47001079,47.5222786290005
2018,2018,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2739,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",175,"","","Gender","Male","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","GENDER","GENM",-77.036871,38.907192
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","HIS",-80.7126401349997,38.6655102020005
2018,2018,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",515,"","","Gender","Female","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","GENDER","GENF",-100.118421049,47.4753197790005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",434,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","BLK",-84.7749710479997,37.6459702710005
2019,2019,"IA","Iowa","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4690,"","","Race/Ethnicity","White, non-Hispanic","POINT (-93.81649055599968 42.46940091300047)",19,"CVD","CVD1_4","NMBR","RACE","WHT",-93.8164905559997,42.4694009130005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4377,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2018,2018,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1082,"","","Gender","Male","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","GENDER","GENM",-68.9850313359996,45.2542288940005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",563,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",3448,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2018,2018,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",64,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_4","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",162,"","","Race/Ethnicity","Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","HIS",-84.7143902699997,44.6613195430005
2019,2019,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2114,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2018,2018,"CO","Colorado","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4594,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.13361092099967 38.843840757000464)",8,"CVD","CVD1_4","NMBR","RACE","WHT",-106.133610921,38.8438407570005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",606,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2738,"","","Overall","Overall","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","OVERALL","OVR",-111.587130635,39.3607001710005
2019,2019,"ME","Maine","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2081,"","","Overall","Overall","POINT (-68.98503133599962 45.254228894000505)",23,"CVD","CVD1_4","NMBR","OVERALL","OVR",-68.9850313359996,45.2542288940005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",952,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",1921,"","","Gender","Female","POINT (-80.71264013499967 38.66551020200046)",54,"OVC","OVC5_0","NMBR","GENDER","GENF",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Alcohol","Chronic liver disease mortality","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-108.10983035299967 43.23554134300048)",56,"ALC","ALC6_0","NMBR","RACE","API",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6483,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2019,2019,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","RACE","AIAN",-92.4456800709997,31.3126606440005
2018,2018,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",87,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","RACE","AIAN",-100.373530637,44.3531300530005
2019,2019,"ND","North Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",43,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-100.11842104899966 47.47531977900047)",38,"CVD","CVD1_4","NMBR","RACE","AIAN",-100.118421049,47.4753197790005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",6698,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",374,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3145,"","","Gender","Male","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","GENDER","GENM",-86.6318607619997,32.8405711220005
2018,2018,"NY","New York","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13765,"","","Race/Ethnicity","White, non-Hispanic","POINT (-75.54397042699964 42.82700103200045)",36,"CVD","CVD1_4","NMBR","RACE","WHT",-75.5439704269996,42.8270010320005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","RACE","API",-80.7126401349997,38.6655102020005
2019,2019,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3936,"","","Gender","Male","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","GENDER","GENM",-92.5663000529997,38.6357907760005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2018,2018,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","AIAN",-117.071840564,39.4932403900005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",102,"","","Race/Ethnicity","Hispanic","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","HIS",-97.5210702139997,35.4720313560005
2019,2019,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",20,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","RACE","AIAN",-81.9289605389997,28.9320403770005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from cerebrovascular disease (stroke)","Number",429,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_5","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"SD","South Dakota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1394,"","","Overall","Overall","POINT (-100.3735306369997 44.353130053000484)",46,"CVD","CVD1_4","NMBR","OVERALL","OVR",-100.373530637,44.3531300530005
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","RACE","AIAN",-92.2744907429997,34.7486501240004
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",39,"","","Race/Ethnicity","Hispanic","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","HIS",-114.363730042,43.6826300050005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",228,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","API",-74.2736912879997,40.1305700480005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1193,"","","Race/Ethnicity","White, non-Hispanic","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","RACE","WHT",-106.240580985,34.5208809520005
2018,2018,"OH","Ohio","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1462,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-82.40426005599966 40.06021014100048)",39,"CVD","CVD1_4","NMBR","RACE","BLK",-82.4042600559997,40.0602101410005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2784,"","","Gender","Female","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","GENDER","GENF",-111.763811277,34.8659702800005
2019,2019,"WV","West Virginia","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",64,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CKD","CKD1_0","NMBR","RACE","BLK",-80.7126401349997,38.6655102020005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6450,"","","Race/Ethnicity","White, non-Hispanic","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","WHT",-120.155031326,44.5674494240005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_1","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",220,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Overarching Conditions","Premature mortality among adults aged 45-64 years","Number",37,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"OVC","OVC5_0","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2019,2019,"WV","West Virginia","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying cause among adults aged >= 45 years","Number",782,"","","Gender","Male","POINT (-80.71264013499967 38.66551020200046)",54,"COPD","COPD1_1","NMBR","GENDER","GENM",-80.7126401349997,38.6655102020005
2019,2019,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4285,"","","Gender","Female","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","GENDER","GENF",-72.0826906749996,42.2768704700005
2019,2019,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2776,"","","Overall","Overall","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","OVERALL","OVR",-99.3657206229997,41.6410409880005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2936,"","","Gender","Male","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","GENDER","GENM",-97.5210702139997,35.4720313560005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1179,"","","Gender","Male","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","GENDER","GENM",-114.363730042,43.6826300050005
2018,2018,"MI","Michigan","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1363,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-84.71439026999968 44.6613195430005)",26,"CVD","CVD1_4","NMBR","RACE","BLK",-84.7143902699997,44.6613195430005
2018,2018,"RI","Rhode Island","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1498,"","","Overall","Overall","POINT (-71.52247031399963 41.70828019300046)",44,"CVD","CVD1_4","NMBR","OVERALL","OVR",-71.5224703139996,41.7082801930005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4271,"","","Gender","Female","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","GENDER","GENF",-89.8163707419997,44.3931911740005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",107,"","","Race/Ethnicity","Hispanic","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","RACE","HIS",-76.6092601109996,39.2905809640005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7251,"","","Race/Ethnicity","White, non-Hispanic","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","WHT",-94.7942005029997,46.3556487360005
2019,2019,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",47,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","RACE","API",-111.587130635,39.3607001710005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","RACE","AIAN",-80.7126401349997,38.6655102020005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1369,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","BLK",-86.6318607619997,32.8405711220005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",743,"","","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3205,"","","Race/Ethnicity","White, non-Hispanic","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","WHT",-89.5380308249997,32.7455100990005
2018,2018,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8494,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","RACE","WHT",-86.1499601939997,39.7669104520004
2018,2018,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6781,"","","Overall","Overall","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","OVERALL","OVR",-84.7749710479997,37.6459702710005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","White, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","WHT",-108.109830353,43.2355413430005
2018,2018,"MO","Missouri","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-92.56630005299968 38.635790776000476)",29,"CVD","CVD1_4","NMBR","RACE","AIAN",-92.5663000529997,38.6357907760005
2019,2019,"KY","Kentucky","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-84.77497104799966 37.645970271000465)",21,"CVD","CVD1_4","NMBR","RACE","API",-84.7749710479997,37.6459702710005
2018,2018,"NJ","New Jersey","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",513,"","","Race/Ethnicity","Hispanic","POINT (-74.27369128799967 40.13057004800049)",34,"CVD","CVD1_4","NMBR","RACE","HIS",-74.2736912879997,40.1305700480005
2019,2019,"WV","West Virginia","NVSS","Diabetes","Mortality due to diabetes reported as any listed cause of death","Number",2607,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"DIA","DIA1_1","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"IN","Indiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4724,"","","Gender","Male","POINT (-86.14996019399968 39.766910452000445)",18,"CVD","CVD1_4","NMBR","GENDER","GENM",-86.1499601939997,39.7669104520004
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_3","NMBR","RACE","HIS",-108.109830353,43.2355413430005
2019,2019,"MD","Maryland","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2990,"","","Gender","Female","POINT (-76.60926011099963 39.29058096400047)",24,"CVD","CVD1_4","NMBR","GENDER","GENF",-76.6092601109996,39.2905809640005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6894,"","","Gender","Male","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","GENDER","GENM",-88.9977101779997,40.4850102830005
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",99,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","API",-94.7942005029997,46.3556487360005
2018,2018,"MT","Montana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1378,"","","Overall","Overall","POINT (-109.42442064499971 47.06652897200047)",30,"CVD","CVD1_4","NMBR","OVERALL","OVR",-109.424420645,47.0665289720005
2019,2019,"OK","Oklahoma","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",31,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-97.52107021399968 35.47203135600046)",40,"CVD","CVD1_4","NMBR","RACE","API",-97.5210702139997,35.4720313560005
2018,2018,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2019,2019,"WY","Wyoming","NVSS","Chronic Kidney Disease","Mortality with end-stage renal disease","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Black, non-Hispanic","POINT (-108.10983035299967 43.23554134300048)",56,"CKD","CKD1_0","NMBR","RACE","BLK",-108.109830353,43.2355413430005
2019,2019,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",154,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","RACE","AIAN",-111.763811277,34.8659702800005
2018,2018,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",106,"","","Race/Ethnicity","Hispanic","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","RACE","HIS",-78.4578904629997,37.5426806740005
2019,2019,"MS","Mississippi","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-89.53803082499968 32.745510099000455)",28,"CVD","CVD1_4","NMBR","RACE","AIAN",-89.5380308249997,32.7455100990005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7458,"","","Race/Ethnicity","White, non-Hispanic","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","WHT",-83.6275803459997,32.8396810930005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",6294,"","","Gender","Female","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","GENDER","GENF",-79.1592504629996,35.4662209750005
2018,2018,"KS","Kansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",179,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-98.20078122699965 38.34774030000045)",20,"CVD","CVD1_4","NMBR","RACE","BLK",-98.2007812269996,38.3477403000005
2019,2019,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",13654,"","","Gender","Female","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","GENDER","GENF",-99.4267702059997,31.8272404070005
2018,2018,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","RACE","API",-147.722059036,64.8450799570005
2018,2018,"NM","New Mexico","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1967,"","","Overall","Overall","POINT (-106.24058098499967 34.52088095200048)",35,"CVD","CVD1_4","NMBR","OVERALL","OVR",-106.240580985,34.5208809520005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",1390,"","","Overall","Overall","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","OVERALL","OVR",-108.109830353,43.2355413430005
2018,2018,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Asian or Pacific Islander","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","RACE","API",-114.363730042,43.6826300050005
2019,2019,"TN","Tennessee","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7793,"","","Race/Ethnicity","White, non-Hispanic","POINT (-85.77449091399967 35.68094058000048)",47,"CVD","CVD1_4","NMBR","RACE","WHT",-85.7744909139997,35.6809405800005
2019,2019,"NV","Nevada","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",130,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-117.07184056399967 39.493240390000494)",32,"CVD","CVD1_4","NMBR","RACE","API",-117.071840564,39.4932403900005
2018,2018,"MA","Massachusetts","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7370,"","","Race/Ethnicity","White, non-Hispanic","POINT (-72.08269067499964 42.27687047000046)",25,"CVD","CVD1_4","NMBR","RACE","WHT",-72.0826906749996,42.2768704700005
2018,2018,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",22,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","API",-86.6318607619997,32.8405711220005
2019,2019,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from total cardiovascular diseases","Number",614,"","","Gender","Female","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_1","NMBR","GENDER","GENF",-108.109830353,43.2355413430005
2019,2019,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3587,"","","Gender","Male","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","GENDER","GENM",-81.0453712069997,33.9988213030005
2018,2018,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",116,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2018,2018,"DC","District of Columbia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","Hispanic","POINT (-77.036871 38.907192)",11,"CVD","CVD1_4","NMBR","RACE","HIS",-77.036871,38.907192
2018,2018,"AZ","Arizona","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",5986,"","","Overall","Overall","POINT (-111.76381127699972 34.865970280000454)",4,"CVD","CVD1_4","NMBR","OVERALL","OVR",-111.763811277,34.8659702800005
2018,2018,"WY","Wyoming","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"CVD","CVD1_4","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3316,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","RACE","API",-120.999999538,37.6386401230005
2019,2019,"GA","Georgia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",122,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-83.62758034599966 32.83968109300048)",13,"CVD","CVD1_4","NMBR","RACE","API",-83.6275803459997,32.8396810930005
2019,2019,"OR","Oregon","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",54,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-120.15503132599969 44.56744942400047)",41,"CVD","CVD1_4","NMBR","RACE","AIAN",-120.155031326,44.5674494240005
2019,2019,"ID","Idaho","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2353,"","","Overall","Overall","POINT (-114.3637300419997 43.682630005000476)",16,"CVD","CVD1_4","NMBR","OVERALL","OVR",-114.363730042,43.6826300050005
2018,2018,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",324,"","","Race/Ethnicity","White, non-Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","WHT",-157.857749403,21.3048504350004
2019,2019,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",45,"","","Race/Ethnicity","American Indian or Alaska Native","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","RACE","AIAN",-94.7942005029997,46.3556487360005
2019,2019,"CA","California","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",19121,"","","Gender","Male","POINT (-120.99999953799971 37.63864012300047)",6,"CVD","CVD1_4","NMBR","GENDER","GENM",-120.999999538,37.6386401230005
2019,2019,"WY","Wyoming","NVSS","Asthma","Asthma mortality rate","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"AST","AST4_1","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"LA","Louisiana","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2976,"","","Gender","Female","POINT (-92.44568007099969 31.31266064400046)",22,"CVD","CVD1_4","NMBR","GENDER","GENF",-92.4456800709997,31.3126606440005
2019,2019,"CT","Connecticut","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",34,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-72.64984095199964 41.56266102000046)",9,"CVD","CVD1_4","NMBR","RACE","API",-72.6498409519996,41.5626610200005
2018,2018,"SC","South Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3377,"","","Gender","Female","POINT (-81.04537120699968 33.998821303000454)",45,"CVD","CVD1_4","NMBR","GENDER","GENF",-81.0453712069997,33.9988213030005
2018,2018,"UT","Utah","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",1360,"","","Gender","Male","POINT (-111.58713063499971 39.360700171000474)",49,"CVD","CVD1_4","NMBR","GENDER","GENM",-111.587130635,39.3607001710005
2019,2019,"WY","Wyoming","NVSS","Chronic Obstructive Pulmonary Disease","Mortality with chronic obstructive pulmonary disease as underlying or contributing cause among adults aged >= 45 years","Number",429,"","","Gender","Male","POINT (-108.10983035299967 43.23554134300048)",56,"COPD","COPD1_2","NMBR","GENDER","GENM",-108.109830353,43.2355413430005
2019,2019,"AL","Alabama","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4848,"","","Race/Ethnicity","White, non-Hispanic","POINT (-86.63186076199969 32.84057112200048)",1,"CVD","CVD1_4","NMBR","RACE","WHT",-86.6318607619997,32.8405711220005
2019,2019,"WI","Wisconsin","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",336,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-89.81637074199966 44.39319117400049)",55,"CVD","CVD1_4","NMBR","RACE","BLK",-89.8163707419997,44.3931911740005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",62,"","","Race/Ethnicity","Hispanic","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","RACE","HIS",-157.857749403,21.3048504350004
2018,2018,"PA","Pennsylvania","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",8714,"","","Gender","Male","POINT (-77.86070029399963 40.79373015200048)",42,"CVD","CVD1_4","NMBR","GENDER","GENM",-77.8607002939996,40.7937301520005
2019,2019,"VA","Virginia","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",9089,"","","Overall","Overall","POINT (-78.45789046299967 37.54268067400045)",51,"CVD","CVD1_4","NMBR","OVERALL","OVR",-78.4578904629997,37.5426806740005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from coronary heart disease","Number",3265,"","","Overall","Overall","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_3","NMBR","OVERALL","OVR",-80.7126401349997,38.6655102020005
2019,2019,"WY","Wyoming","NVSS","Diabetes","Mortality with diabetic ketoacidosis reported as any listed cause of death","Number",0,"~","Data not shown because of too few respondents or cases","Race/Ethnicity","American Indian or Alaska Native","POINT (-108.10983035299967 43.23554134300048)",56,"DIA","DIA1_2","NMBR","RACE","AIAN",-108.109830353,43.2355413430005
2018,2018,"NC","North Carolina","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",55,"","","Race/Ethnicity","Asian or Pacific Islander","POINT (-79.15925046299964 35.466220975000454)",37,"CVD","CVD1_4","NMBR","RACE","API",-79.1592504629996,35.4662209750005
2018,2018,"TX","Texas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",3153,"","","Race/Ethnicity","Black, non-Hispanic","POINT (-99.42677020599967 31.827240407000488)",48,"CVD","CVD1_4","NMBR","RACE","BLK",-99.4267702059997,31.8272404070005
2019,2019,"AK","Alaska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",252,"","","Gender","Male","POINT (-147.72205903599973 64.84507995700051)",2,"CVD","CVD1_4","NMBR","GENDER","GENM",-147.722059036,64.8450799570005
2018,2018,"MN","Minnesota","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",7618,"","","Overall","Overall","POINT (-94.79420050299967 46.35564873600049)",27,"CVD","CVD1_4","NMBR","OVERALL","OVR",-94.7942005029997,46.3556487360005
2019,2019,"HI","Hawaii","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",705,"","","Gender","Male","POINT (-157.85774940299973 21.304850435000446)",15,"CVD","CVD1_4","NMBR","GENDER","GENM",-157.857749403,21.3048504350004
2018,2018,"AR","Arkansas","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",4343,"","","Overall","Overall","POINT (-92.27449074299966 34.74865012400045)",5,"CVD","CVD1_4","NMBR","OVERALL","OVR",-92.2744907429997,34.7486501240004
2018,2018,"FL","Florida","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",21731,"","","Overall","Overall","POINT (-81.92896053899966 28.932040377000476)",12,"CVD","CVD1_4","NMBR","OVERALL","OVR",-81.9289605389997,28.9320403770005
2019,2019,"IL","Illinois","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",459,"","","Race/Ethnicity","Hispanic","POINT (-88.99771017799969 40.48501028300046)",17,"CVD","CVD1_4","NMBR","RACE","HIS",-88.9977101779997,40.4850102830005
2019,2019,"WV","West Virginia","NVSS","Cardiovascular Disease","Mortality from diseases of the heart","Number",4947,"","","Race/Ethnicity","White, non-Hispanic","POINT (-80.71264013499967 38.66551020200046)",54,"CVD","CVD1_2","NMBR","RACE","WHT",-80.7126401349997,38.6655102020005
2018,2018,"NE","Nebraska","NVSS","Cardiovascular Disease","Mortality from heart failure","Number",2544,"","","Race/Ethnicity","White, non-Hispanic","POINT (-99.36572062299967 41.6410409880005)",31,"CVD","CVD1_4","NMBR","RACE","WHT",-99.3657206229997,41.6410409880005
